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Abstract
For more than two decades, tuberculosis (TB) has ranked second among the top killers of
infectious diseases, with an estimated 10.4 million incident cases in 2018. Demographic
characteristics and drug susceptibility influence TB incidence worldwide. Using a
retrospective cohort design, the purpose of this quantitative study was to investigate
whether race/ethnicity, age, sex (gender), therapy completion within one year (COT), and
testing for isoniazid and rifampin susceptibility (TIRS) were predictors of 672 cases of
TB in New York-Newark-Jersey City from 1993 to 2017. Guided by the epidemiological
triad theory, this research was conducted using a secondary TB dataset from the Center
for Disease Control and Prevention. Analysis of the data with the Poisson regression
model on SPSS revealed that Blacks, Hispanics, and Asians were respectively 2.4 (95%
Cl, 2.364 to 2.512, p < 0.001), 2.1 (95% Cl, 2.031 to 2.161; p < 0.001), 1.8 (95% Cl,
1.782 to 1.899; p < 0.001) times as likely to have TB compared to Whites. Younger age
was significantly associated with higher incident cases of TB. Males were 1.58 (95% Cl,
1.554 to 1.613, p < 0.001) times more likely than females to have the disease. The COT
and TIRS were 0.175 (95% Cl, 0.170 to 0.180, p < 0.001) and 2.935 (95% Cl, 2.853 to
3.019, p < 0.001) times as likely to impact the TB incident cases in New York-NewarkJersey City from 1993 to 2017. The findings of this research may create positive social
change by informing public health professionals in the design of an effective TB
intervention that addresses demographic and therapy-related risk factors for TB in New
York-Newark-Jersey City.
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Chapter 1: Introduction to the Study
Introduction
Despite the directed priorities of New York City Department of Health in
providing healthcare and treatments for TB patients, the race/ethnicity and covariates,
age, sex (gender), and issues of TB therapy completion and drug susceptibility
persistently influenced the escalation of TB incidence in New York-Newark-Jersey City.
According to research, non-Hispanic Asians, non-Hispanic Blacks, and Hispanics have
regularly experienced more TB incident cases than their non-Hispanic White counterparts
from this region in New York City (Knorr, Meissner, Perri, & Ahuja, 2013; Kyanko,
Tsay, Yun, & Parent, 2016; Marks et al., 2014; Stennis et al.,2015l; Zelnick, O'Donnell,
Ahuja, Chua, & Meissner, 2016). Notably, both the age and sex demographics have
impacted the incidence of TB in New York-Newark-Jersey City. Regardless of their
gender or age groups, the non-Hispanic Asian, non-Hispanic Black, and Hispanic
residents have persistently experienced the highest burden of TB in New York-NewarkJersey City (Bushnell, Stennis, Drobnik, Proops, & Ahuja, 2015; Gounder et al., 2015;
Stennis et al., 2015). Therefore, race/ethnicity, age, and sex risk factors impacted the
elevated incident cases of TB in this area in New York City.
Previous studies partially established the relationship between the demographic
characteristics of patients and the incidence of TB in New York-Newark-Jersey City.
However, the results did not clearly demonstrate the impact of TB on non-Hispanic
Asians, non-Hispanic Blacks, Hispanics, and non-Hispanic Whites from 1993 to 2017 in
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New York-Newark-Jersey City. Poverty, alcohol consumption, poor housing, and lack of
access to TB care risk factors associated with the high TB incident cases among the nonHispanic Black and Hispanic TB patients in New York-Newark-Jersey City (Sanderson
et al., 2015; Slutsker, Trieu, Crossa, & Ahuja, 2017; Stennis et al., 2017; Zelnick et al.,
2016). In addition, researchers found that tobacco use is a contributing risk factor for the
burden of TB among non-Hispanic Asians at this specified location in New York City
(Stennis et al., 2015). However, these researchers did not clearly indicate the reasons for
the low burden of TB incidence among the non-Hispanic Whites from this location in
New York City. Therefore, the purpose of this study was to investigate the relationship
between the individuals’ race/ethnicity, age, sex (gender), completion of therapy within
one year, testing for isoniazid and rifampin susceptibility, and the TB incident cases
between 1993 and 2017 in New York-Newark-Jersey City.
The results of this study could create positive social change by promoting the
design of an effective TB intervention about the individuals’ race/ethnicity and
covariates, age, sex (gender), and issues of therapy and drug susceptibility in New YorkNewark-Jersey City. Chapter one of this study includes background information on TB,
the problem statement, and the rationale for conducting this research from this area in
New York City. Additionally, it encompasses the nature of the study, research questions
and hypotheses, definitions, assumptions, limitations, significance, and a summary
section. It is worthwhile noting that TB is an emerging infectious disease affecting the
livelihood of people worldwide.

3
Background of Tuberculosis
TB incidence is historically associated with specific demographic characteristics
of patients and treatment issues. Lin et al. (2013), and Noppert et al. (2017), indicated
that researchers have regularly found the race/ethnicity, age, and sex (gender)
demographics as contributing risk factors for the incidence of TB in a given population.
Zhang et al. (2011), argued about the disparity in race/ethnicity, age, or sex (gender) of
persons as the contributing risk factors for different paths of exposures to TB in most
advanced and developed countries in the world. From a therapeutic approach, the issue of
TB therapy has recently challenged the goal of ending TB, globally. In 2017, more than
30% of the global TB diagnoses have been connected to the multidrug-resistant issue,
including the rifampin TB drug treatment (World Health Organization [WHO], 2017, p.
67). Despite the amelioration in TB diagnosis and the availability of drug treatments, the
complications in therapy and drug susceptibility have recently impacted the global
incidence trends of TB.
The issues of TB therapy and treatments present a burden for eradicating TB,
globally. The exposure of TB patients to isoniazid and rifampicin drug treatments is often
associated with poor treatment outcomes among many TB patients in the world (Ahmed,
Shukla, Fatima, Varshney, & Shameem, 2017; Menzies et al., 2018; WHO, 2017).
However, the lack of adherence to some patients in completing TB therapy is also
associated with the increasing number of TB incident cases worldwide. Similarly, the
failure of some patients to adhere to the quality of care and medications for their TB
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disease is a global problem (Glaziou, de la Paz, Sismanidis, Floyd, & Raviglione, 2014;
WHO, 2017). This behavior is often associated with unsuccessful treatment stories and a
high incidence of the disease worldwide (Glaziou et al., 2014; WHO, 2017). The health
beliefs of some TB patients have also prevented them from obtaining the quality of care
required to cure their TB disease.
The conceptions of some patients about TB are contributing risk factors for the
incidence of TB worldwide. These perceptions are characterized as the health beliefs and
misconceptions of some patients about their TB disease (Asres, Gedefaw, Kahsay, &
Weldu, 2017; Fuge, Bawore, Solomon, & Hegana, 2018; Osei, Akweongo, & Binka,
2015). Religious beliefs in using holy water and misconception about the appropriate
time for receiving TB treatments are also associated with the high incidence of the
disease within their communities (Asres et al., 2017; Fuge et al., 2018; Osei et al., 2015).
Bullying is also associated with the lack of or non-adherence of some patients to TB care.
Bullying has an influence on the morbidity and mortality of TB worldwide. As
such, the stigmatization has been found to be attributed to the delays of TB diagnoses and
treatments among many TB patients worldwide (Asres et al., 2017; Fuge et al., 2018;
Osei et al., 2015). Additionally, a lack of or low adherence to TB care and treatments
often led them to experience the atrocity and high mortality rate of TB (Glaziou et al.,
2014; WHO, 2017, pp. 63-86). However, the cost of TB care is exorbitant.
The high cost of health care is a contributing risk factor for the elevated incidence
of TB in some parts of the world. The lack of health insurance coverage and high cost of
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TB care and treatments are also attributing risk factors for the escalation of TB incidence
in several communities in the world (Asres et al., 2017; Fuge et al., 2018; Osei et al.,
2015). TB is a global health threat to humanity.
Despite its decline in other areas of the world, TB has continued to affect people
in the United States. However, its incident cases have been substantially decreased
starting from 2013 to 2017 (Haddad et al., 2018; Miramontes et al., 2015; Salinas et al.,
2016; Schmit, Wansaula, Price, & Langer, 2017; Stewart, Tsang, Pratt, Price, & Langer,
2018). Additionally, the TB incident cases were varied by the individuals’ demographic
characteristics within several communities in the United States. The heterogeneity in the
incident cases of TB in the United States has long been associating with the
race/ethnicity, age, sex (gender), and country of origin of some TB patients (Miramontes
et al., 2015; Stennis, Trieu, Ahuja, and Harris, 2014; Stennis et al., 2015; Stennis et al.,
2017; Zelnick et al., 2016). Similarly, non-Hispanic Asian, non-Hispanic Black,
Hispanic, Native Hawaiian, and other Pacific Islander persons have experienced a
disproportionate burden of TB incident cases, regardless of their age and gender
orientation in the United States (CDC, 2016; Schmit et al., 2017; Stewart et al., 2018). As
such, the demographic characteristics of patients had influenced the escalation of TB
incidence between 1993 and 2017 in New York-Newark-Jersey City.
Despite its reduction nationally, the reported TB incident cases have been
consistently high in New York-Newark-Jersey City. From 2010 to 2013, the incidence of
TB estimated to approximately 8.7 cases and slightly decreased to 7.5 cases per 100,000
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in 2017 from this area in New York City (New York City Department of
Health and Mental Hygiene, 2017, p. 5; Stennis et al., 2015). The demographic
characteristics of patients partially influenced the incident cases TB for more than 25
years in New York-Newark-Jersey City.
Researchers have shown the influence of race/ethnicity, age, and gender of
patients in the high incidence rate of TB in New York-Newark-Jersey City. However,
little is known about the impact of TB therapy incompletion and drug susceptibility on
the elevated incident cases of TB for more than a decade from this region in New York
City. Recently, the issues of therapy and drug susceptibility have been evaluated as the
potential risk factors for the increased TB incident cases, globally. Likewise, the
race/ethnicity and its covariates, age and gender have been influential in the increased
incident cases of TB worldwide.
For the past five years, the highest TB incident cases have been detected in Asian,
African, and Hispanic countries. Likewise, race/ethnicity, age, and sex (gender)
demographics have been influential in the increased TB incident cases in New YorkNewark-Jersey City. Consequently, this study may be of immense public health
significance by exploring whether the race/ethnicity, age, and sex (gender) of patients
associated with the elevated TB incident cases between 1993 and 2017 from New YorkNewark-Jersey City. Additionally, the significance of this study is in its originality by
attempting to determine whether the issues of TB therapy and drug susceptibility were
connected to the phenomena of TB in New York-Newark-Jersey City.
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Problem Statement
Demographic characteristics and issues of therapy completion and drug
susceptibility have influences on the burden of TB incidence in New York-NewarkJersey. From 2013 to 2017, non-Hispanic Asian, non-Hispanic Black, and Hispanic
individuals experienced the highest burden of TB incidence from New York-NewarkJersey City (New York City Bureau of Tuberculosis Control, 2016; Stennis et al., 2017;
Zelnick et al., 2016). In contrast, their non-Hispanic White counterparts regularly
experienced a low burden of TB in New York- Newark-Jersey (New York City Bureau of
Tuberculosis Control, 2016, p. 16; Stennis et al., 2017). Hence, these demographic
characteristics have been influential risk factors for the incidence of TB during the past
decade in New York-Newark-Jersey City.
The age demographic is a contributing risk factor for TB in New York-NewarkJersey City. Sanderson et al. (2015), Slutsker et al., and Ahuja (2017) estimated that the
affliction of TB is associated with more elders and children, aged five and under in the
above area of New York City. As such, the gender demographic is also an attributable
risk factor for TB in New York-Newark-Jersey City. Being female is a risk factor for
getting TB from this metropolitan area of New York (Katyal, Leibowitz, & Venters,
2018; Stennis et al., 2017). More specifically, females are more likely than their male
counterparts to be diagnosed with TB in New York-Newark-Jersey City (Katyal et al.,
2018; & Stennis et al., 2017). Researchers have argued that the individuals’
race/ethnicity, age, and gender are partially influenced by the elevated TB incident cases
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from 2012 to 2017. However, they have not indicated how these demographic
characteristics of patients were associated with the increasing TB incident cases from this
region in New York City.
There is uncertainty in the risk factors for TB in New York-Newark-Jersey City.
Stennis et al. (2015) and Stennis et al. (2017) argued that substance and tobacco use and
alcohol consumption are associated risk factors for the high burden of TB among nonHispanic Asians, non-Hispanic Blacks, Hispanics, and some non-Hispanic White persons
New York-Newark-Jersey City. However, living in incarceration and in health care
facilities are also the contributing risk factors for the upsurge TB incident cases in New
York-Newark Jersey City from 2013 to 2017 (Katyal et al., 2018; Schmitt et al., 2017).
Thus, the residence is a risk factor for TB transmission in New York-Newark-Jersey City.
Poor housing is a potential risk factor for TB in New York-Newark-Jersey.
Sanderson et al. (2015), Stennis et al. (2017), and Slutsker et al. (2017) argued that living
in poor houses or buildings is associated with transmitting TB from person to person in
New York-Newark-Jersey City. It has also been argued that high cost of TB care and
treatments are related to the increasing TB incident cases among the poor and migrant
persons at this specific location in New York City (Bhavnani, Lancki, Winter, &
Macaraig, 2015; Bushnell et al., 2015; Zelnick et al., 2016). Furthermore, the lack of
adherence of some patients to TB care and treatments is a potential risk factor for the
reoccurring TB incident cases in New York- Newark-Jersey.
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The lack of or non-adherence of some patients to TB care and treatments are
common risk factors for an increasing incidence of TB in a population. Bhavnani et al.
(2015), Bushnell et al. (2015), and Zelnick et al. (2016) contended that the inadequate
adherence of some TB patients to seeking care has often resulted in the interruption of
and incomplete treatments and high incidence of TB in New York-Newark-Jersey City.
Researchers have shown the influence of demographic characteristics of patients on the
incident cases of TB from 2012 to 2017 from this area in New York City. However, little
research has been conducted about the impact of inadequate TB therapy completion and
drug susceptibility issues on TB incident cases in New York-Newark-Jersey City.
Purpose of the Study
The purpose of this quantitative study was to investigate the relationship between
demographic characteristics, issues of therapy completion, isoniazid and rifampin
susceptibility, and the TB incident cases between 1993 and 2017 in New York-NewarkJersey City. Using the retrospective cohort study design, this quantitative analysis was
conducted by using the 1993-2017 TB dataset from the online tuberculosis information
system (OTIS) database of the CDC. Of this dataset, the age, sex, race/ethnicity,
completion of therapy within one year, and testing for isoniazid and rifampin
susceptibility were the independent variables for this study. The TB incident cases were
the dependent variable for this research. The Poisson regression model was used for the
analysis of data associated with these variables.
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Research Questions and Hypotheses
The following research questions and hypotheses were formulated using the
variables, race/ethnicity, age, and sex, completion of therapy within one year, tested for
isoniazid and rifampin susceptibility, and the TB incident cases between 1993 and 2017
in New York-Newark-Jersey City.
RQ1. Is there a relationship between race/ethnicity and covariates (age and sex),
and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey City?
H0 1. There is no relationship between race/ethnicity and covariates (age and sex),
and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
H1 1. There is a relationship between race/ethnicity and covariates (age and sex),
and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
RQ2. Is there a predictive relationship between the completion of therapy within
one year and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey
City?
H0 2. There is no predictive relationship between the completion of therapy within
one year and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey
City.
H1 2. There is a predictive between completion of therapy within one year and the
TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
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RQ3. Is there a predictive relationship between tested for isoniazid & rifampin
susceptibility the TB incident cases between 1993 and 2017 in New York-Newark-Jersey
City?
H0 3. There is no predictive relationship between tested for isoniazid & rifampin
susceptibility the TB incident cases between 1993 and 2017 in New York-Newark-Jersey
City.
H1 3. There is a predictive relationship between tested for isoniazid & rifampin
susceptibility and the TB incident cases between 1993 and 2017 in New York-NewarkJersey City.
Theoretical Framework
The epidemiological triad theory is commonly used to guide the investigation of
an infectious disease in a given population. This theory is appropriate for exploring the
age and gender of infected persons and environmental risk factors connected to the
occurrence of an infectious disease in a population. The epidemiological triad theory was
useful in helping me with exploring the relationship of race/ethnicity, age, sex of TB
patients, and the TB incident cases from 2011 to 2018 in New York-Newark-Jersey City.
The epidemiological triad theory is relevant to this study. According to the CDC
(2012) and Morabia (2013), this theory is the best philosophical perspective for
investigating an infectious disease from a population. Additionally, the epidemiological
triad theory is fundamental to understanding the host-pathogen interaction from various
environmental risk factors in a given population (CDC, 2012; Morabia, 2013). The
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environmental risk factors may be based on the issues of geology, climate, biological, and
socioeconomic status (e.g., crowding, sanitation, & availability of health services) of
people in an environment (CDC, 2012). As such, the epidemiological triad theory is
relevant to this research on the interaction of Mycobacterium tuberculosis with the human
host in New York-Newark-Jersey City.
Nature of the Study
This study was a quantitative analysis focused on a retrospective cohort study to
investigate TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
A quantitative study allows researchers to collect and analyze an existing dataset to
interpret an outcome of interest from a population (Burkholder, Cox, & Crawford, 2016;
Ludwig & Johnston, 2016). The Poisson regression model was used to analyze the
relationship between race/ethnicity, age, and sex demographics, completion of therapy
within one year, testing for isoniazid and rifampin susceptibility, and the TB incident
cases from New York-Newark-Jersey City during 1993-2017.
Terms and Definitions
Active and latent tuberculosis: active TB has often exhibited its symptoms in an
infected host; however, the latent state of TB is asymptomatic inside the infected host
(Johnson et al., 2017; Khatua et al., 2017; WHO, 2013, p. 18).
Airborne disease: is an infectious disease caused by pathogens expelled and
suspended in the air through the droplet nuclei (e.g., coughing and sneezing) of an
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infected person and transmitted to other persons inhaling them in a given environment
(Maine Centers for Disease Control and Prevention, n.d.).
Communicable disease: is a contagious disease caused by an infectious agent
through direct contact with an infected person or indirectly from other sources in an
environment (United States Department of Health and Human Services, n.d.).
Demographic characteristics: are numerous characteristics (e.g., age, gender,
race/ethnicity, income level, education level, marital status, geographic areas, etc.) of a
study population (Center for Research in the Apostolate, n.d.; New Mexico's IndicatorBased Information System, n.d.).
TB drug susceptibility testing: is a term denoting intolerability of the
Mycobacterium tuberculosis species to some TB drug treatments in some TB patients
(TBFACTS.org, n.d.).
Foreign-born persons: the persons, who were not born in the U. S., but may
become naturalized U.S. citizens (United States Census Bureau, 2016).
Host: is defined as a human being or an animal that is used as a reservoir of an
infectious disease (Ashford, 2003).
Mycobacterium tuberculosis: is the causative agent of the TB disease (CDC,
2016).
New York-Newark-Jersey City: “is the largest metropolitan area in the United
States” (City Population, n.d., Table. 1).
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Race/ethnicity: has referred to the racial and ethnic background of a person (New
York City Department of Health and Mental Hygiene, n.d.). While Hispanics are
originated from various races, Asians, Blacks, Whites, American Indian/Alaska Natives,
Native Hawaiians or other Pacific Islanders, and multi-racial individuals are considered
as the non-Hispanic ethnic groups (New York City Department of Health and Mental
Hygiene, n.d.).
Socioeconomic status: is the social and economic conditions, which have often
determined the eligibility of persons in accessing health care in a given community
(Towne, 2017).
U.S. born persons: the persons that are eligible to become the citizens of the
United States at birth, regardless of the land, where they were born (CDC, 2018).
Assumptions
An assumption about the incidence of TB in New York-Newark-Jersey City was
that the disease affected the persons of diverse ethnicities through various risk factors.
Researchers found different kinds of risk factors associated with the incident cases of TB
from 2011 to 2017 from this area in New York City. Another assumption of this research
was that the illegal immigration status could represent a barrier for the Hispanic and
Asian ethnic groups in accessing care and treatments for their TB disease. Such a
challenge could lead them to experience a surmounted level of TB incident cases in New
York-Newark-Jersey City. A key assumption was that the low socioeconomic status of
the non-Hispanic Asian, non-Hispanic Black and Hispanic ethnic minorities could
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influence their high burden of TB incidence from this region in New York City. Although
these assumptions were likely accurate, there was heterogeneity in how the residents of
New York-Newark-Jersey City are affected by TB.
Scope and Delimitations
Research has indicated a relationship between race/ethnicity, age, and gender of
patients, and the incident cases of TB in New York-Newark-Jersey City. However, in this
study, the scope is limited to demonstrating how the demographic characteristics of TB
patients directly exposed them to TB in this area of New York City. Previous studies on
TB indicated that the non-Hispanic Asian, non-Hispanic Black, and Hispanic individuals
have experienced the highest burdens of TB from this region in New York. However,
there is ambiguity in the reasons for a disadvantage in TB incident cases among ethnic
minorities in this area of New York City. Also, the researchers of these studies did not
investigate the connection between TB therapy completion, drug susceptibility, and the
trends of TB incidence in New York-Newark-Jersey City. Moreover, these studies were
not guided by a theoretical or conceptual framework through which the relationship
between race/ethnicity, age, sex (gender) of patients, and the incident cases of TB could
be investigated in this metropolitan area of New York.
For this study, the epidemiological triad theory was adopted as the philosophical
guidance for exploring the relationship between the race/ethnicity, age, and sex
demographics, therapy completion within one year, testing for isoniazid and rifampin
susceptibility, and the TB incident cases between 1993 and 2017 in New York-Newark-
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Jersey City. The theorist of this framework has suggested researchers can use the theory
to understand the relationship between an infectious agent, host, and environmental risk
factors that may provoke the incidence of such an infectious disease in a population.
Thus, this theory was feasible for exploring how the non-Hispanic Asian, non-Hispanic
Black, Hispanic, non-Hispanic Whites, and multiracial persons directly related to the
incident of TB during 1993-2017 in this area in New York City. This study was designed
to represent the general population of TB patients in New York-Newark-Jersey City.
Limitations
Using the publicly available 1993-2017 TB dataset was considered a limitation to
this study. However, such a limitation was minimal knowing that the CDC, a reputable
agency for collecting health data, was the collector and organizer of the TB dataset.
Because I was not the primary collector of the above TB dataset, I was unable to control
for the inherent biases associated with collecting data from the TB patients in New YorkNewark-Jersey City from 1993-2017. This study was also limited in analyzing data of
certain ethnic groups of TB patients because of the missing data and cases, with zero
values from the 1993-2017 TB data set for New York-Newark-Jersey City. Notably, the
cases, with excess zero values were inconclusive by not indicating whether the members
of a certain ethnic group were affected by TB between 1993 and 2017 in New YorkNewark-Jersey City (see CDC, 2018). Consequently, the statistical analysis of this
research was strictly limited to the availability of data and variables reported in the OTIS
database.
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Significance
This study may be of immense public health significance by emphasizing the need
for an effective TB intervention focusing on the demographic characteristics of TB
patients, issues connected to therapy completion and isoniazid and rifampin
susceptibility, and prevention of future TB occurrences in New York-Newark-Jersey
City. Stennis et al. (2015), Stennis et al. (2017), and Zelnick et al. (2016) argued that
foreign births, poverty, lack of insurance coverage, illegal immigration status are the
contributing risk factors for the elevated incident cases of TB from this area in New York
City. However, little research was conducted on the impact of inadequate TB therapy
completion and drug susceptibility issues on the escalation of TB incident cases between
1993 and 2017 in New York-Newark-Jersey City.
Investigating the relationship between the individuals’ race/ethnicity, age, and sex
(gender), therapy incompletion, isoniazid, and rifampin susceptibility, and the TB
incident cases between 1993 and 2017 was imperative for working toward eradicating TB
in New York-Newark-Jersey City. The findings of this study might impact positive social
change by evoking the public health professionals to design a TB intervention focused on
issues connected to demographic variables, therapy incompletion, and isoniazid and
rifampin susceptibility in this area in New York City. Likewise, it is important to educate
the non-Hispanic Asian, non-Hispanic Black, Hispanic, non-Hispanic White, and
multiracial ethnic groups about TB risk factors in this area in New York City. The
findings of this study may also be helpful in advancing the knowledge of TB research.
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Summary
In Chapter 1, I discussed evidence on the relationship between the demographic
characteristics of patients and TB incident cases between 2011 and 2017 in New YorkNewark-Jersey City. Additionally, this chapter included the rationale for conducting this
TB research in New York-Newark-Jersey City, the purpose of the study, nature of the
study, research questions and hypotheses, theoretical foundation, terms and definitions,
assumptions, limitations, and significance of this study. In Chapter 2, I provide a review
of the literature on the demographic characteristics of TB patients and therapy issues in
New York-Newark-Jersey City.
Chapter 2: Literature Review
Introduction
The purpose of this study was to investigate whether the demographic
characteristics of TB patients and issues related to TB therapy completion and isoniazid
and rifampin susceptibility were associated with the escalation of TB incident cases
between 1993 and 2017 in New York-Newark-Jersey City. The hypotheses of this
research included the independent variables of race/ethnicity, age, sex (gender), cases that
completed therapy within one year, and the cases with initial susceptibility to isoniazid
and rifampin. The dependent variable was TB incident cases during 1993 to 2017 in New
York-Newark-Jersey City. Many researchers indicated that these demographic
characteristics of TB patients have influenced the burden of TB incidence between 2011
and 2018 in this area in New York City. However, there is little research on the
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relationship between TB therapy completion, drug susceptibility issues, and the
phenomena of TB in New York-Newark-Jersey City. Therefore, the purpose of this study
was to investigate the relationship between the individuals’ race/ethnicity, age, sex
(gender), completion of therapy within one year, testing for isoniazid and rifampin
susceptibility, and the TB incident cases from 1993 to 2017 in New York-Newark-Jersey
City.
Chapter 2 of this study includes reviews of the literature on the epidemiology and
pathophysiology of TB, and TB diagnoses and treatments in New York-Newark-Jersey
City, the United States, and abroad. Additionally, I discuss the epidemiological triad
theory and its applicability to this study based on previous studies of TB.
Literature Search Strategy
The literature search strategy involved in the use of databases from the Walden
University Library to obtain evidence related to the incidence of TB in New YorkNewark-Jersey City. Of the various databases, the Medline with Full Text, PubMed,
CINAHL Plus with Full Text, and ProQuest Central were selected to find the peer-review
articles for this study. The literature search was narrowed to peer-review articles and
journals that were published within five years or less. Furthermore, evidence on the
incidence of TB in New York City, United States, and abroad was sought using the
websites of WHO, CDC, and New York City Bureau of Tuberculosis Control. as the
following keywords were used in the search: race/ethnicity, age, gender, health care
services, tuberculosis, socioeconomic status, therapy issues, Tuberculosis drug-resistant,
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and New York. In many instances, the search was narrowed to text or title as a strategy to
obtain the articles for this research on TB.
Theoretical Foundation
The epidemiological triad theory was served as the guidance of this study. A
theoretical framework is the foundation of the literature review in a research study (Grant
& Osanloo, n.d.). Such a component of research has, in part, informed about the
structure, research questions, and hypotheses of a study (Grant & Osanloo, n.d.). From
these perspectives, the research questions and hypotheses of this study were formulated
using the independent variables, age, sex (gender), COT, and TIRS to investigate the
incident cases of TB in New York-Newark-Jersey City during 1993-2017. Notably, the
incidence of an infectious disease may be based on various environmental risk exposures
of a population.
The epidemiological triad theory predicts these environmental risk exposures as
the socio-economic conditions, under which a community has lived in (CDC, 2012, para.
7). These conditions may be linked to inadequate health care services, poor hygiene, and
overcrowding housings that have often exposed the members of a community to an
infectious disease (CDC, 2012, paras. 6-7). In this study, the issues of therapy and drug
susceptibility were, in part, considered as the conditions that influenced the incident cases
of TB in New York-Newark-Jersey City from 1993 to 2017.
The epidemiological triad theory has not assumed race/ethnicity to be an intrinsic
risk factor for infectious disease in a population. However, the relationship between
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race/ethnicity and the incidence of TB was investigated in New York-Newark-Jersey City
during the past 25 years.
Literature Review
Epidemiology of Tuberculosis
TB is catastrophic across the globe. The pandemic of TB has been estimated to
more than 10 million new cases yearly, starting from 2014 to 2018 (Glaziou et al., 2014;
WHO, 2017, p. 1; WHO, 2018, p. 1), and more than 2 billion latent cases from 2014 to
2018 worldwide (Menzies et al., 2018; Teklu et al., 2018; WHO, 2015). However, the
epidemiological trends of TB have been influenced by other health issues.
For the past five years, human immunodeficiency virus (HIV) patients have been
vulnerable to acquiring and developing TB. For instance, HIV infected patients had the
highest incidence of TB from 2012 to 2017 worldwide (Friedrich, 2018; Glaziou et al.,
2014; WHO, 2017, p. 1; WHO, 2018, p. 1). In addition, the global morbidity and
mortality rates of TB have been recently elevated. From 2012 to 2017, the global
mortality rate of TB was estimated at 1.3 million cases yearly (Badawi et al., 2015; CDC,
2017, para. 1; Houben & Dodd, 2016). However, the HIV infected patients were more
likely to die from TB than their counterparts who did not have the HIV infection
(Friedrich, 2018; Gupta-Wright et al., 2018; WHO, 2017, p. 21). However, TB is more
detrimental to some persons in some countries and regions in the world.
For the past 25 years, TB has been more common in certain continents and
regions of the world. For instance, the Eastern area of Asia was the most afflicted region,
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with more than 40% of the world's TB epidemic from 2013 to 2017 (Glaziou et al., 2014;
WHO, 2017, p. 2; WHO, 2018, p. 32). Likewise, the African and Western Pacific regions
ranked second and third, with approximately 25% and 17 % of the global TB incident
cases respectively in 2016 (WHO, 2017, p. 2; WHO, 2018, p. 32). However, the Eastern
Mediterranean, European, and Americas correspondingly accounted for nearly 8%, 3%,
and 3%, respectively, of the global incidence rate of TB from 2012 to 2017 (Glaziou et
al., 2014; WHO, 2017, p. 2; WHO, 2018, p. 32).
TB is a multifaceted infectious disease with various risk exposures. From 2012 to
2017, malnutrition, smoking habit, diabetes, HIV, and poverty have been evaluated as the
most frequent risk factors for the incidence of TB worldwide (Badawi et al., 2015;
McLaren, Schnippel, & Sharp, 2016; Millet et al., 2013; WHO, 2017, p. 3). HIV
infection and drug resistance, however, have been evaluated as the most challenging risk
factors controlling for TB across the globe during 2012-2017 (Glaziou et al., 2014; Millet
et al., 2013; WHO, 2018, p. 1). Additionally, HIV patients are more likely than those
without HIV to develop TB, and most of them have lived in low-income countries in
Africa and Asia (Glaziou et al., 2014; Millet et al., 2013; WHO, 2018).
Drug resistance is associated with elevated incident cases of TB worldwide. From
2013 to 2018, multidrug-resistant TB (MDR-TB) and extensive drug-resistance were
among the most dominant risk factors for treatment failure among TB patients worldwide
(Glaziou et al., 2014; Millet et al., 2013; WHO, 2018, p. 67). Most of the MDR-TB cases
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were detected in Eastern Europe and Central Asia during 2013-2016 TB incidence
worldwide (Glaziou et al., 2014; Tupasi et al., 2016).
Race/ethnicity is an associated risk factor for the incidence of TB in the United
States. The national incidence rate of TB in the United States is estimated between 2.8
and 3.0 cases per 100,000 from 2012 to 2016 Salinas et al., 2016; Schmit et al.,2017;
Scott, Kirking, Jeffries, Price, & Pratt, 2015; Stewart et al., 2018). However, the
incidence rate of TB among people outside of the United States is estimated to more than
15.0 cases per 100,000 (Salinas et al., 2016; Schmit et al., 2017; Stewart et al., 2018).
However, there is a disparity in the distribution of TB among people outside of the
United States.
There is heterogeneity in the attribution of people outside of the United States to
the incident cases of TB within the United States. Non-Hispanic Asians persistently
experienced the highest burden of TB, with approximately 27 cases per 100,000,
followed by non-Hispanic Blacks and Hispanics, with roughly 22 and 10.0 cases per
100000 (Salinas et al., 2016; Schmit et al., 2017; Stewart et al., 2018). However,
regarding country of origin, Mexico-born persons, people born in the Philippines,
Indians, the Vietnamese, and Chinese immigrants attributed more than 50 % of the
national TB incident cases from 2014 to 2017 in the United States (Schmit et al., 2017;
Scott et al., 2015; Stewart et al., 2018). Although the people outside of the United States
have had the highest burden of TB, American-born persons are also infected with the
disease.
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The incident cases of TB are low among American-born persons. From 2012 to
2017, the incidence rate of TB has been estimated between 1.0 and 1.8 cases per 100000
American-born persons in the United States (Salinas et al., 2016, Schmit et al., 2017;
Stewart et al., 2018). However, this ethnic group of TB patients has experienced the
disparity in their attributions in the incident cases of the disease nationally. From 2014 to
2017, non-Hispanic Blacks experienced a disproportionate burden of nearly 30% of the
TB incident cases among American-born TB patients (Scott et al., 2015; Schmit et al.,
2017; Stewart et al., 2018). Conversely, Schmit et al. (2017) and Stewart et al. (2018)
estimated that the Native Hawaiians and Pacific Islanders had the highest burden of TB,
with approximately 6.5 cases per 100,000 during this period in the United States. On the
other hand, On the other hand, Schmit et al. (2017) and Stewart et al. (2018) argued that
the American Indians/Alaska Natives and non-Hispanic Blacks are categorized as the
second and third ethnic groups, with the highest TB incident rates of approximately 3.6
and 2.8, respectively in the United States. TB has also infected other American-born
persons.
Among the American-born persons, the non-Hispanic Asian, Hispanic, and nonHispanic White Americans have experienced the lowest TB incidence rates. These ethnic
groups accounted for approximately 2.0, 1.5, 0.4 TB incident cases per 100, 000,
respectively from 2014 to 2017 in the United States (Scott et al., 2015; Stewart et al.,
2018; Schmit et al., 2017). However, regardless of its disparity across diverse ethnic
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groups, TB is a public health threat in several states, communities, and regions in the
United States.
Despite its low incidence on the national level, TB has impacted the livelihood of
hundreds of persons in New York-Newark-Jersey City, yearly. Lately, the incidence rate
of TB in New York City varied from 8.0 cases in 2012 to 7.4 in 2014, and 7.5 cases per
100,000 in 2017 (Brown et al., 2016; Bushnell et al., 2015; New York City Bureau of
Tuberculosis Control, 2017, p. 5). Such an escalation of TB incidence in this part of New
York associated with the youths (e.g., ages 18 and under) and elders (e.g., age 65 and
older), males, foreigners, and the U.S.-born Hispanics (New York City Bureau of
Tuberculosis Control, 2017, p. 16; Zelnick et al., 2016). The high incidence of TB in
New York-Newark Jersey City associated with the lack of TB care and treatment for
some TB patients.
The issues of TB care and treatments are linked to the high TB incidence rate in
New York-Newark-Jersey City. From 2012 to 2017, the delays in TB diagnoses and
treatments have been associated with the escalation of TB incidence in this area of New
York City (Harris, Meissner, & Proops, 2013; New York City Bureau of Tuberculosis
Control, 2017). Also, the race/ethnicity demographic has an influence on the elevated
incident cases of TB for the past decade from this region in New York.
The race/ethnicity risk factor is associated with the high incident rate of TB in
New York-Newark-Jersey City. From 2014 to 2018, non-Hispanic Asian, non-Hispanic
Black, Hispanic, and non-Hispanic White foreigners experienced more than 15 incident
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cases of TB per 100,000 from this area in New York City (New York City Bureau of
Tuberculosis Control, 2016; Scott et al., 2015; Stewart et al., 2018). Conversely, the U.S.born Asians, Blacks, Hispanics, and Whites only accounted for 6.3 cases per 100, 000,
combined (New York City Bureau of Tuberculosis Control, 2016). Educated on the
pathology of the Mycobacterium tuberculosis species is also important for physicians and
public health professionals to eradicate TB in New York-Newark-Jersey City.
Pathophysiology of Tuberculosis
TB is an airborne and communicable disease. Such an infectious disease is
transmissible from person to person (Glaziou et al., 2018; Maine Centers for Disease
Control and Prevention, n.d., para. 1; Mandal, 2019). Often, a person has acquired TB by
inhaling the Mycobacteria from coughing, speaking, and sneezing of a TB-infected
person (Glaziou et al., 2018; Maine Centers for Disease Control and Prevention, n.d.,
para 1; Mandal, 2019; Orme, Robinson, & Cooper, 2015). After inhaling the
Mycobacterium tuberculosis, a person may develop either the active or latent state of TB
depending on the strength of the immune system of this person (Arroyo, Marín, Franken,
Ottenhoff, & Barrera, 2018; CDC, 2017, para. 2; Herzmann et al., 2017). While the
Mycobacterium tuberculosis has remained latent in patients of strong immune systems, it
has changed into active in those, with weak or compromised immune systems (CDC,
2017, para, 2; National Institutes of Allergy and Infectious Disease [NIAID], para. 1;
Sizemore, Hafner, & Fauci, 2018). The Mycobacterium tuberculosis is subdivided into
several types.
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Understanding the diversity in characteristics of the Mycobacterium species is
important for an effective TB diagnosis. Although the Mycobacterium species are of
different types, they are similar in low permeability of their cell walls (Jagielski et al.,
2016; Sun, Li, Xu, & Huang, 2015). However, these microorganisms are different in
infecting either humans or animals. Whereas Mycobacterium tuberculosis and
Mycobacterium Bovis have infected humans and animals, the Mycobacterium Canettii
and Mycobacterium Africanum species have only infected humans (Delogu, Sali, &
Fadda, 2013; Jagielski et al., 2016). Contrarily, the Mycobacterium Caprae has infected
goats, Mycobacterium microti has infected the immunocompromised persons, and
Mycobacterium pinnipedii is often seen in infected seals (Delogu et al., 2013; Jagielski et
al., 2016). At the cellular level, the Mycobacterium tuberculosis species has attacked the
alveolar organ of the host.
The Mycobacterium tuberculosis agent has disabled the alveolar macrophage to
infect the lungs of its host. Research indicated that the macrophage is an antigen that has
engulfed or killed the foreign particles attempting to invade the immune system of a host
(Chatterjee, 2015; Lavalett, Ortega, Sadee, Schlesinger, & Barrera, 2017; Orme et al.,
2015). However, in many instances, the Mycobacterium tuberculosis species has been
observed in inhibiting the function of T-lymphocytes and immune response of the
alveolar macrophages to survive within a TB-infected person or animal (Lavalett et al.,
2017; Macdonald et al., 2012; Orme et al., 2015). Once escaping the acidic environment
of the alveolar macrophages, the Mycobacterium tuberculosis can infect the lungs of its
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infected host (Ravimohan, Kornfeld, Weissman, & Bisson, 2018). Thus, the disability of
alveolar macrophages is proportional to the ability of Mycobacterium tuberculosis
species in infecting the lungs.
The inflammatory condition of alveolar has become a suitable environment for
the development of TB. Of the granulomatous or inflammatory cell structure of the lungs,
the Mycobacterium tuberculosis agent has transformed itself into the pulmonary TB
infection (Orme et al., 2015; Ravimohan et al., 2018; Rodrigues et al., 2013). The
contagious TB infection, however, has remained latent in patients with strong immune
systems and active in those of weak immune systems (Sukumar, Tan, Aldridge, &
Russell, 2014; Uradhi, 2015). While the cellular interaction of Mycobacterium
tuberculosis has informed about the immune system of the host, education on the
molecular aspect of this Mycobacterium species is crucial for diagnosing and treating TB
patients.
Studying the molecular interaction of Mycobacterium TB is of immense public
health significance to eradicate tuberculosis worldwide. Research indicated that having
educated on the relationship of the molecular kinetics with specific strains of
Mycobacterium tuberculosis in the immune system of a host is critical for making an
effective vaccine for TB (Kim et al., 2015; Mortaz et al., 2014; Sukumar et al., 2014).
Such a suggestion has been made based on the variability in the interaction of the
Mycobacterium tuberculosis inside the immune system. Likewise, previous studies
indicated that the Mycobacterium tuberculosis has often interacted with many types of
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cytokines to infect the lungs of its host (Chatterjee, 2015; Kim et al., 2015; Mortaz et al.,
2014). Thus, the interaction of Mycobacterium tuberculosis has involved several types of
cytokines while causing TB within the lungs of an infected person or animal.
Depending on its strain, the Mycobacterium tuberculosis species have behaved
differently with specific types of cytokines. The H37Rv strain of Mycobacterium
tuberculosis, for instance, might inhibit the macrophages from secreting tumor necrosis
factor (TNF) and interleukin-12 (IL-12) cytokines that may have prevented it from
invading the immune system of a host (Chatterjee, 2015; Kim et al., 2012; Olsen et al.,
2016). The dysfunction of macrophages is critical for the survival of Mycobacterium
tuberculosis inside the host. Similarly, research indicated that such an action of the
H37Rv strain has often sustained the Mycobacterium tuberculosis agent in obliterating
the production of TNF and nitric oxide in its favor to survive, grow, and transform into
pulmonary tuberculosis within the immune system of such a host (Chatterjee, 2015; Kim
et al., 2012; Mortaz et al., 2014; Olsen et al., 2016). The K-strain of the Mycobacterium
tuberculosis, on the contrary, has interacted with different kinds of cytokines within the
immune system of the host.
The interaction of K-strain of Mycobacterium tuberculosis is critically important
for developing a vaccine and an effective diagnosis of TB. Kim et al. (2015) and Park et
al. (2014) and argued that the K-strain of Mycobacterium tuberculosis is an informative
tool for differentiating the latent and active TB in diagnosing patients, suspected with the
disease, and in those that are susceptible to TB drug treatments. Unlike the H37Rv, the
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K-strain of Mycobacterium tuberculosis regularly disabled the production of IFN-γ and
IL-17 cytokines causing TB in the lungs of a host (Arroyo et al., 2018; Park et al., 2014;
Kim et al., 2015). Additionally, the K-strain of Mycobacterium tuberculosis has been
estimated to be a more toxic cytokine than its counterpart H37RV strain in producing
granulation or inflammation to the lungs of a host (Kim et al., 2015; Kim et al., 2017; &
Mahamed et al., 2017). While the immune response has differed with various strains of
the Mycobacterium tuberculosis species, the molecular interaction of this microorganism
is fatal to the immune system of its infected host.
The worst actions of the Mycobacterium tuberculosis have been seen in its
molecular interaction. Of such a biological interaction, the lungs of TB patients have
developed the cavitation and necrosis mechanism (Butler et al., 2017; Mahamed et al.,
2017; Ravimohan et al., 2018; Subbian et al., 2015). Under the necrotic condition,
Mycobacterium tuberculosis has disabled the mitochondria and plasma membrane easing
the entry of the infected Mycobacteria into the alveoli macrophages (Butler et al., 2017;
Mahamed et al., 2017; Ravimohan et al., 2018). Through the process of necrosis,
Mycobacteria have grown extensively and formed the cavitation in the lungs of a host
(Butler et al., 2017; Mahamed et al., 2017; Ong, Elkington, & Friedland, 2014). During
this evolution, TB has become contagious by releasing of extensive amount of bacilli on
the air from coughing or sneezing of a TB-infected person to other uninfected ones in a
given environment (Butler et al., 2017; Mahamed et al., 2017; Ravimohan et al., 2018;
Ong et al., 2014). Thus, understanding the molecular function of the Mycobacterium
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tuberculosis within the immune system of a host is crucial for diagnosing and preventing
TB in a given population.
Diagnosis of Tuberculosis
Careful diagnosis of TB is imperative for the global eradication of the disease.
However, effective diagnoses of TB have required the in-depth TB knowledge of
physicians to contribute to the elimination of this infectious disease worldwide (Condrau,
2010; Hoffman et al., 2016). Likewise, these healthcare providers could help achieve the
goal of eliminating TB globally, with their accuracy in diagnosing and treating TB
patients (Johnson et al., 2017; Tagliani, Alagna, Tafaj, Hafizi, & Cirillo, 2017). Thus, the
knowledge of the physicians in TB is needed for an accurate diagnosis of the disease.
To be effective in testing patients for TB, the health care providers must know the
symptoms of the disease. These health care providers might be successful in diagnosing
TB, with their careful analyses of sputum of their patients within the first few weeks of
exposure to the Mycobacterium tuberculosis species (Meng et al., 2017; Tagliani et al.,
2017). Additionally, they must familiarize themselves with symptoms, such as chest pain,
fatigue, weight loss, lack of appetite, chills, fever, sweating at night times to be effective
in detecting TB in their patients (CDC, 2016, para. 6; Johnson et al., 2017; Mandal, 2019;
WHO, 2013, p. 19). Knowing the symptoms of TB is also important for examining
patients; however, the process of diagnosing them is a challenge.
Diagnosing TB is complicated. Such a challenge is associated with the inaccuracy
connected to the tuberculin skin test (TST) and QuantiFERON-TB-Gold assay (QFT-
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GIT) diagnostic techniques in testing patients suspected with TB (Ahmadinejad, Ardalan,
Razzaqi, Davoudi, & Jafarian, 2013; Kim et al., 2018; Niguse et al., 2018). Often, the
TST has been used for diagnosing patients suspected of TB, but it is limited in revealing
whether the infection is latent or active (Ahmadinejad et al., 2013; Kim et al., 2018;
Niguse et al., 2018). Additionally, the TST often yielded false positive or false negative
results analyzing the bloodstream of some patients under investigation for TB
(Ahmadinejad et al., 2013; Kim et al., 2018; Niguse et al., 2018). In many instances, the
inaccuracy of TST has necessitated other advanced examinations for TB in many
patients.
A chest X-ray is a more tangible test for examining patients suspected with.
Often, many health care providers used a chest x-ray exam to analyze if TB is active or
latent in their patients (Ahmadinejad et al., 2013; Chao, Wu, & Shieh, 2016; Johnson et
al., 2017). The difficulty associated with TB diagnoses has obligated some healthcare
providers to be selective in their methods of diagnosing persons suspected with the
disease.
The detection of latent TB is dynamic. Auguste et al. (2016), Chang, Wang, and
Chen (2017), and Johnson et al. (2017) argued that some diagnostic tests are inaccurate in
their results and are lacking in specifying whether TB is latent or active (Auguste et al.,
2016; Chang et al., 2017; Johnson et al., 2017). Consequently, the physicians and other
health care providers are required to be careful in interpreting the test results of their TB
patients (Auguste et al., 2016; Chang et al., Chang et al., 2017; Johnson et al., 2017).
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Testing whether TB is latent or active in patients is important for the successful treatment
of TB patients. To investigate the latent state of TB, some physicians often chose the
tuberculin skin test (TST) or Gold In-Tube Test (QFT-G) release assay (IGRA) using the
blood specimen of their patients to ascertain if TB is latent in their patients (Ahmadinejad
et al., 2013; Johnson et al., 2017; Kruczak et al., 2014). However, disparity does exist in
the efficacy of these diagnostic tests.
The Gold In-Tube Test (QFT-G) release assay (IGRA) is a more effective
diagnostic test than its counterpart TST. Ahmadinejad et al. (2013), Kim et al. (2018),
and Niguse et al. (2018) argued that the TST is well known for yielding false positive and
false negative results of a TB diagnostic test. Conversely, the QFT is more likely than the
TST to reveal an accurate result of a TB diagnostic test (Ahmadinejad et al., 2013; Kim et
al., 2018; Niguse et al., 2018). Despite the challenges associated with TST and Gold InTube Test (QFT-G) release assay (IGRA), the detection of the latent state of TB is
possible through a chest X-ray exam.
Effective diagnoses of latent TB are associated with an X-ray exam, besides the
TST and QFT diagnostic tests. Ahmadinejad et al. (2013) and Johnson et al. (2017)
explained that when a positive result of TST or QFT is associated with a negative chest
X-ray, this has indicated that TB is latent. Hence, the diagnosis of latent TB has required
the good judgment of some physicians and other health care providers in selecting a
relevant diagnostic test for an accurate result of a TB diagnosis.
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Examining patients for active TB has required an advanced level of testing.
Previous studies indicated that health care providers often utilized acid-fast bacilli in the
sputum of suspected TB patients to detect this infectious disease through the smear
microscopy test (Carniel et al., 2014; Johnson et al., 2017; Niguse et al., 2018). Such a
testing technique has been found to be cost-effective and useful in detecting the acid-fast
bacilli and confirming whether TB is active in some patients (Carniel et al., 2014; Keflie
& Ameni, 2014; Johnson et al., 2017). Despite its advantages, many researchers have
recommended the use of other diagnostic tests over the smear microscopy for testing
active TB in patients.
The Xpert MTB/RIF or GeneXpert) molecular test is more effective than the
smear microscopy test. Desikan (2013), Law et al. (2018), and Shuaib et al. (2018)
argued that despite its widespread use in diagnosing TB, the smear microscopy test is
limited to establishing the dissimilarity between the smears of Mycobacterium
tuberculosis and non-tuberculosis Mycobacterium. Furthermore, this testing technique
regularly confounded the acid-fast bacilli positive smears for negative acid-fast bacilli
(Desikan, 2013; Law et al., 2018; & Shuaib et al., 2018). Additionally, it has been found
to be less effective in specifying or detecting the sensitivity of the Mycobacterium
tuberculosis species (Desikan, 2013; Law et al., 2018; Shuaib et al., 2018). Contrarily,
the Xpert MTB/RIF diagnostic test has proven to be a more rapid and accurate test than
its counterpart smear microscopy in differentiating the smears of Mycobacterium
tuberculosis and nontuberculous bacteria (Desikan, 2013; Law et al., 2018; Shuaib et al.,
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2018). However, there has been criticism associated with the Xpert MTB/RIF diagnostic
test.
The Xpert MTB/RIF diagnostic test is expensive. Despite being more efficient
than the smear microscopy test, the cost of the Xpert MTB/RIF test oftentimes limited its
use in most low-income and poor countries of the world (Desikan, 2013; Law et al.,
2018; Shuaib et al., 2018). Both the Xpert MTB/RIF and smear microscopy tests are
highly recommended for diagnosing TB. However, there are other advanced diagnostic
tests required for examining patients, suspected with TB.
Newer assays are available for detecting the multiple and extensively drugresistant Mycobacterium tuberculosis. Desikan (2013) and Lavania et al. (2017) argued
that the DNA amplification and oligonucleotide probe hybridization, Line Probe Assay
(LPA), and multiple drug-resistant TB (MTBDR) are viable diagnostic tools for detecting
multiple drug-resistant in some TB patients. After diagnosing patients with TB, the
health care providers have prescribed appropriate drug regimens to treat their TB
patients.
Treatments for Tuberculosis
TB is curable. The CDC (2017), Jinbo, Lustik, West, and Kloetzel (2017), and
Johnson et al. (2017), noted that the isoniazid therapy is commonly used to treat patients,
with the latent TB. However, some health care providers have often recommended a
different dose of this treatment for different types of TB patients. Isoniazid therapy is
required daily for nine months in HIV infected patients, children up to 11 years old, and
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twice a day with pyridoxine/vitamin B6 in pregnant women, with TB (CDC, 2017, table.
1; Jinbo et al., 2017). However, the Isoniazid therapy and Rifapentine are recommended
once a week for three months in latent TB patients, aged 12 and older (Borisov et al.,
2018; CDC, 2017, table. 1; Jinbo et al., 2017; Johnson et al., 2017). The treatments for
patients with active tuberculosis are different.
The treatment regimen for patients, with active TB, is a combination of several
drugs. The CDC (2017) and Johnson et al. (2017) argued that patients, who diagnosed
with negative culture for the Bacillus bacterium, are recommended to take the isoniazid
therapy, rifampicin, ethambutol, pyrazinamide, and ethambutol regimen once daily for at
least three months. Conversely, those, who diagnosed with a positive culture for Bacillus
bacterium, are administered with the Isoniazid and rifampicin drug treatments for 18
weeks (Borisov et al., 2018; Johnson et al., 2017). A theory is a concept of
philosophizing on an event based on existing data.
The Epidemiological Triad Theory and its Applicability in Previous Tuberculosis
Research
The epidemiological triad theory is used as a guide for this research on
tuberculosis in New York-Newark-Jersey City. Such a philosophy was first speculated in
the nineteenth century and developed by Wade Hampton Frost into a full theory
beginning in the twentieth century (Comstock, 2006; Morabia, 2013). The
epidemiological triad theory has suggested that the incidence of an infectious disease is
often based on the interactions of a causative agent, host, and environmental factors in a
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given population (CDC, 2012, paras. 4-7; James, 2017; Morabia, 2013). The causative
agent, however, maybe a microorganism or virus, which has caused an infectious disease
in the hosts (CDC, 2012, para. 4; James, 2017; Morabia, 2013). These hosts may be
human beings or animals in which the causative agent has caused the infectious disease
(CDC, 2012, para. 5; James, 2017; Morabia, 2013). The host-pathogen is the primary
interaction in the development of an infectious disease in an environment.
Investigating the environmental risk factors that prompted the incidence of an
infectious in a population is important. The environmental risk factors were the social
circumstances, which have often exposed some persons to an infectious disease in a given
population (CDC, 2012; James, 2017; Morabia, 2013). Consequently, informing about
the lifestyle of a study population is also crucial for researchers in investigating the
incidence of an infectious disease in a given population. As such, research indicated that
having educated on the host-pathogen interaction is crucial for researchers to discover the
risk factors for the occurrence of an infectious disease in a given population (CDC, 2012;
James, 2017; Morabia, 2013). Adopting the epidemiological triad theory, this study
explored the relationship between the Mycobacterium tuberculosis species, human host,
and environmental risk factors that elicited the incidence of TB from 1993 to 2017 in
New York-Newark-Jersey City.
For the host-pathogen interaction to exist, the Mycobacterium tuberculosis must
have produced some types of biomarkers to infect the cell of its hosts. Many researchers
indicated that the type VII- ESX protein secretion system is such biomolecule upon
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which the Mycobacterium tuberculosis has relied for transportation of proteins through
the immune system of a host (Deng, Xiang, & Xie, 2014; Elliott & Tischler, 2016;
Simeone, Bottai, Frigui, Majlessi, & Brosch, 2015). Furthermore, such a biomarker (e.g.,
type VII-ESX protein system) has been found in previous studies to play a crucial role in
obliterating the alveolar cell causing TB in the lungs of such a host (Deng et al., 2014;
Elliott & Tischler, 2016; Simeone et al., 2015). However, other researchers thought that
the cyclic AMP has mostly used by Mycobacterium tuberculosis to modify the cell of its
hosts.
The cyclic AMP has frequently involved in the host-pathogen interaction of
Mycobacterium tuberculosis. Previous studies found that the cyclic AMP is a protein
regulator molecule, which is often seen in the host-pathogen interaction within the
immune system of an infected host (Green et al., 2014; Knapp & McDonough, 2014; Lee,
Lang, Fortune, Sassetti, & Alber, 2012). However, research also indicated that the
primary role of the cyclic AMP is to control the expressions of genes within the
Mycobacterium tuberculosis species during while causing TB inside the lungs of such a
host (Green et al., 2014; Knapp & McDonough, 2014; Lee et al., 2012). The hostpathogen interaction has occurred by the influence of some environmental factors in a
given population.
The epidemiological triad theorist has encouraged researchers to investigate the
relationship between an infectious agent and environmental risk factors. The CDC (2012)
and James (2017) noted that various environmental risk factors, such as biological,
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socioeconomic, and healthcare inequality are common determinants for the incidence of
an infectious disease in a population. Additionally, the age, sex(gender), and behavior of
some patients often influenced their exposures to the Mycobacterium tuberculosis species
in an environment (CDC, 2012, para. 5; James, 2017; Zwerling, Hanrahan, & Dowdy,
2015). These risk factors are also known as the socioeconomic circumstances that have
elicited the transmission of TB from person to person in a population.
The socioeconomic status is a risk factor for TB transmission worldwide.
Likewise, Migliori and Garcia-Basteiro (2018) and Petrol et al. (2017) argued that
poverty is the primary indicator of the global TB incidence trends for past the past
decade. However, unemployment and poor housing were the most frequent risk factors
being observed for the global TB incident cases from 2014 to 2018 (Migliori & GarciaBasteiro, 2018; Petrol et al., 2017). Thus, the socioeconomic status of some persons has
represented a burden for the global elimination of TB.
The eradication of TB must have approached from a socioeconomic perspective.
Previous studies found that the cost associated with caring for TB patients is exorbitant
(Migliori & Garcia-Basteiro, 2018; Pedrazzoli et al., 2017; Wingfield et al., 2016). Such
an economic issue often led to low adherence, discontinuation of TB care, and
unsuccessful treatments among some TB patients across the globe (Migliori & GarciaBasteiro, 2018; Pedrazzoli et al., 2017; Wingfield et al., 2016). The high cost of TB care
and treatments is a challenge for eradicating TB worldwide.
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The low economic status is problematic in attempting to eliminate TB, globally.
Migliori and Garcia-Basteiro (2018), Pedrazzoli et al. (2017), and Wingfield et al. (2016)
argued that unless alleviating the financial burden among the poor, the global elimination
of TB may not be possible. Moreover, research indicated that eradicating TB is possible
by implementing an intervention focusing on reducing the social challenges associated
with poor TB patients in accessing the quality of care and treatments for their TB disease
(Migliori & Garcia-Basteiro, 2018; Pedrazzoli et al., 2017; Wingfield et al., 2016).
Understanding the social barriers connected to the dissemination of TB is also important
for the global elimination of this infectious disease.
Addressing the social challenges in attempting to eradicate TB is imperative for
an effective global TB intervention. From this perspective, Migliori and Garcia-Basteiro
(2018), Pedrazzoli et al. (2017), and Wingfield et al. (2016) thought that such a social
initiative is crucial for preventing the multi-drug resistant, poor clinical adherence,
inaccessibility to TB care among the poor TB patients worldwide. The epidemiological
triad theorist has also suggested researchers investigate the biological risk factors in
relation to the incidence of an infectious disease in a given population.
From a biological perspective, the Mycobacterium tuberculosis agent has
prevented the efficacy of some TB drug treatments in some patients. Such an ideology
supported by Bento, Empadinhas, and Mendes (2015), Esterhuyse et al. (2015), and
Singh, Garg, Rath, and Goyal (2016) in arguing that the host-bacillus interaction is
regularly associated with some unsuccessful cases of TB treatments in
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immunocompromised, elder, and drug-susceptible TB patients. Further, Fukui et al.
(2015), O'Shea and McShane (2016), and Weiner and Kaufmann (2014) argued that the
disruption of the macrophage cells by Mycobacterium tuberculosis or Bovis is often times
associated with the ineffectiveness of the Bacillus Calmette-Guerin vaccine and other TB
therapeutic drug treatments in some TB patients. The Mycobacterium tuberculosis has
also averted the effect of some treatments in TB patients, with imbalance liver enzymes.
Drug-Induced liver injury is a common complication in TB treatments. Such a
condition often influenced an increased level of the liver enzyme or injury in the liver of
some TB patients (Abbara et al., 2017; Naidoo, Evans, Jong, Mellet, & Berhanu, 2015;
Tweed et al., 2018). In many instances, the liver disease or injury resulted in the
susceptibility of some patients to the Isoniazid and other TB drug treatments for their TB
disease (Abbara et al., 2017; Naidoo et al., 2015; Tweed et al., 2018). Often, the
complication of drug-induced injury has resulted in poor TB outcomes in some patients.
Drug-Induced liver injury is fatal to some TB patients. In their studies, Abbara et
al. (2017), Naidoo et al. (2015), Tweed et al. (2018), and von Braun et al. (2017) stated
that the most unsuccessful TB treatment cases often resulted in a deterioration of health
and high mortality rate of some TB patients, with a liver disease. Also, the fatality of the
TB drug-induced liver injury frequently associated with the alcohol abuse, liver disease,
and co-HIV patients at an advanced stage of the TB disease (Abbara et al., 2017; Naidoo
et al., 2015; Tweed et al., 2018; von Braun et al., 2017). Most of the drug-induced liver
injury cases associated with TB patients, aged 35 and older (Abbara et al., 2017; Naidoo
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et al., 2015; Tweed et al., 2018). Other than the biological risk factors, the behaviors of
some patients have played an integral role in the dissemination of tuberculosis
worldwide.
Evidence has shown that the behavioral risk factors of some patients have
associated with their exposures to the contagious Mycobacterium tuberculosis species.
The epidemiological triad theorist has encouraged researchers to investigate the behaviors
of patients in relation to the incidence of infectious diseases, such as tuberculosis in a
given population (CDC, 2012, paras. 5-6; James, 2017). The behavioral risk factors for
transmitting TB from person to person in a population are various. Similarly, the sharing
of space, items, failed adherence to TB care and treatments, and consumption of alcohol
have been found as the associated risk factors for transmitting TB from person to person
in an environment (Prado et al., 2017; Kigozi, Engelbrecht, Heunis, & van Rensburg,
2018; Rogo et al., 2017; Slutsker et al., 2017). Also, the epidemiological triad theorist has
suggested researchers to investigate whether the age and gender of patients are influential
risk factors for the occurrence of an infectious disease in a population.
The age and sex demographics are inherent risk factors for the transmission of TB
in a given population. As such, they played influential roles in the global incidence of TB
in several communities across the globe from 2010 to 2017 (CDC, 2012, para. 6; James,
2017; Morabia, 2013). During a TB investigation, many researchers often focused their
studies on the age and gender of persons to investigate the incidence and mortality risks
of TB in an environment (James, 2017; Morabia, 2013; Zwerling et al., 2015). Speaking
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of the age risk factor, children, aged 17 and under were vulnerable to acquiring latent TB
for the past five years, worldwide (Campos-Outcalt, 2017; Korhonen et al., 2017;
Matteelli et al., 2017). Age is a risk factor for mortality among TB patients.
Estimating the average age for the mortality risk of TB is a challenge. Previous
studies indicated that the global elderly population is disproportionately affected by the
mortality of TB (Gayoso, Dalcolmo, Braga, & Barreira, 2018; Leung et al., 2018;
Morabia, 2013). Conversely, Hannah, Miramontes, and Gandhi (2017) and Zwerling et
al. (2015) argued that such an obstacle to TB is more common among children and young
adult TB patients than their elderly counterparts. Other than age, the epidemiological
triad theorist has suggested that researchers understand the differences in gender of
patients during the investigation of an infectious disease in a population.
Gender or sex (gender) is an influential risk factor for TB transmission
worldwide. Feng et al. (2012) and Yates and Atkinson (2017) argued that men are more
likely than women to be diagnosed with TB. However, such a disparity in the diagnoses
of TB is often seen among TB patients, with social, cultural, and economic hardships
across the globe (Feng et al., 2012; Jankowska-Polanska, Kamińska, Uchmanowicz, &
Rycombe, 2015; Oshi, Alobu, Ukwaja, & Oshi, 2015). As such, the low socioeconomic
status represented a barrier for some women in accessing the quality of care and
treatments for their TB disease during the 2010-2017TB incident cases worldwide (Feng
et al., 2012; Oshi et al., 2015; Jankowska-Polanska et al., 2015). Conversely, Horton,
MacPherson, Houben, White, and Corbett (2016), Oshi et al. (2015), and Yates and
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Atkinson (2017) taught that the indoor air pollution and HIV infection were the most
frequent risk factors for transmitting TB among women in worldwide. Unlike women,
some men have experienced different risk exposures for acquiring and developing TB.
The social lifestyle of some men has provoked their exposure to TB. Horton et al.
(2016), Jankowska-Polanska et al. (2015), and Oshi et al. (2015), and Yates and Atkinson
(2017) argued that unemployment, alcohol consumption, inadequate education, and
loneliness are globally associated with the lack and non-adherence to TB care and
treatments among some men. Specifically, the financial burden of some men often
prevented them from obtaining the quality of care and treatments recommended for
curing their TB disease (Horton et al., 2016; Jankowska-Polanska et al., 2015; Oshi et al.,
2015; Yates & Atkinson, 2017). The epidemiological triad theorist has defined a human
host as the reservoir of an infectious agent; however, humans are diversified in race and
ethnicity.
The race/ethnicity demographic is frequently investigated in the epidemiological
studies of tuberculosis. The individuals’ race/ethnicity regularly influenced the incidence
of TB in the United States (Noppert et al., 2017; Noppert et al., 2017; Wilson, Miller, &
Stimpson, 2016). However, the socioeconomic status of non-Hispanic Asian, Black, and
Hispanic, and White TB patients often determined their attributions in the incidence of
TB for the past 25 years in the United States (Noppert et al., 2017; Noppert et al., 2017;
Wilson et al., 2016). Despite the racial and ethnic disparity among TB patients, they have
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had similar experiences in diagnosing for the disease across the globe, including the
United States.
The inaccuracy in TB diagnoses is associated with some unsuccessful TB
treatment cases across the globe. Researchers indicated that such a delay in TB diagnoses
is connected to the false positive or false negative results of some patients testing for TB
in the United States and abroad (Kim et al., 2018; Nijhawan, Iroh, Brown, Winetsky, &
Porsa, 2016; Wilson et al., 2016). Globally, the inaccuracy in TB diagnoses often affected
the judgment of some physicians and other health care providers in prescribing the
unneeded or unnecessary drug regimens to some of their TB patients (Nijhawan et al.,
2016). Such inaccuracy in results of some TB exams associated with the interruption of
treatments and the death of many TB patients across the globe (Nguyen et al., 2018;
Nijhawan et al., 2016; Wilson et al., 2016). Despite its association in the research of TB,
the race/ethnicity variable has not been emphasized in the epidemiological triad theory.
The race/ethnicity demographic has an influence on the global transmission of
tuberculosis. Consequently, the inclusion of race/ethnicity as a risk factor for
investigating an infectious disease, such as TB in a given population, is highly
recommended to enhance the epidemiological triad theory. Despite its lack of emphasis
on race/ethnicity, this theory has clearly shown the connection of an infectious agent,
host, and environmental risk factors in provoking the incidence of an infectious disease in
a population.
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The epidemiological triad theory is appropriate for this TB research in New YorkNewark-Jersey City. Using this theory, researchers often learned about the interactions of
an infectious agent, host, and environmental risk factors while investigating an infectious
disease in an environment (CDC, 2012, paras. 3-5; James, 2017). Similarly, the
epidemiological triad theory played is feasible for exploring the relationship between the
non-Hispanic Asian, non-Hispanic Black, Hispanic, non-Hispanic White, and multiracial
TB patients from 1993 to 2017 from this area in New York City. Thus, race/ethnicity,
age, and sex (gender) demographics are considered as the intrinsic risk factors for the
incidence of an infectious disease in a given population.
Race/ethnicity, age, and gender have regularly influenced the incidence of TB in a
given population. Thus, the hypotheses of this research are partially drawn on the
race/ethnicity, age, and gender of persons as contributing predictors for the elevated TB
incident rate from 1993 to 2017 in New York-Newark-Jersey City. However, the research
gap for which the justification is needed is in whether inadequate TB therapy completion
and susceptibility of some TB patients to Isoniazid and Rifampin associated with the high
incident rate of TB during this period in New York-York-Newark Jersey City.
Related Evidence on the Escalation of Tuberculosis Incidence from 2011 to 2017 in
New York-Newark-Jersey City
The race/ethnicity has an influence on the incidence trends of TB in New YorkNewark-Jersey City. The illegal immigrant Hispanics, for instance, experienced
inadequate health insurance and high cost of TB care, which have influenced the burden
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of TB in their community between 2015 and 2017 from this area in New York City
(Kyanko, Tsay, Yun, & Parent, 2016; Stennis et al., 2017; Zelnick et al., 2016). Often,
the illegal immigration status of some Hispanic TB patients associated with their
ineligibility for receiving the quality of TB care and treatments for their TB disease in
this region New York (Kyanko et al., 2016; Stennis et al., 2017; Zelnick et al., 2016). As
a result, the lack of immigration status often associated with the unsuccessful TB
treatments and elevated incident cases of TB among the Hispanics in New York City (
Kyanko et al., 2016; Stennis et al., 2017; Zelnick et al., 2016). The escalation of TB
incidence among people from this ethnic group in New York-Newark-Jersey City was
also associated with their behaviors
The social lifestyle and other morbidities are contributing risk factors for the high
burden of TB among the Hispanics in New York-Newark-Jersey City. Similarly, research
indicated that alcohol consumption, substance, and illegal drug use are contributing risk
factors for treatment complications and high incidence of TB among the Hispanics in this
area of New York City (Katyal et al., 2018; Stennis et al., 2017; Zelnick et al., 2016).
Additionally, HIV and diabetes morbidities haven associated with the incidence of TB
among the Hispanics in New York-Newark-Jersey City from 2015 to 2017 (Stennis et al.,
2017; Zelnick et al., 2016). Similarly, the socioeconomic risk factor associated with the
burden of TB within the non-Hispanic Black community in this metropolitan area of New
York.
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The socio-economic risk factor has immensely impacted the high burden of TB
among the non-Hispanic Blacks in New York-Newark-Jersey City. Howley et al. (2015)
and Katyal et al. (2018) indicated that incarceration, unemployment status, and substance
use are related risk factors for TB transmission among the non-Hispanic Blacks in this
part of New York. Additionally, Katyal et al. (2018), Knorr et al. (2013), and Marks et al.
(2016) indicated that homelessness, smoking, and alcohol consumption are contributing
risk factors for TB infection and treatment complications among persons of the above
ethnic group in New York-Newark-Jersey City. Some preexisting health conditions,
however, have been associated with TB among the non-Hispanic Blacks in this area of
New York.
Both HIV and Diabetes are associated with risk factors for the burden of TB
incidence among the Non-Hispanic Blacks in New York-Newark-Jersey City. From 2014
to 2018, HIV and Diabetes have been associated with the incident cases of TB among the
non-Hispanic Blacks from this region in New York City (Howley et al., 2015; Katyal et
al., 2018; Marks et al., 2016). Often, these morbidities associated with TB drug
susceptibility and high mortality rate among the non-Hispanic Black TB patients in New
York-Newark-Jersey City (Marks et al., 2016; Marks et al., 2019). However, nonHispanic Whites have experienced a low burden of TB in this part of New York.
The risk factor for acquiring TB among the non-Hispanic Whites in New YorkNewark-Jersey City is controversial. In their studies, Howley et al. (2015), Sanderson et
al. (2015), Slutsker et al. (2017), and Pagaoa et al. (2015) argued that having contacts
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with an active TB patient is the primary risk factor for transmitting TB among the nonHispanic Whites in New York-Newark-Jersey City. Conversely, the HIV risk factor is
associated with the low burden of TB among the non-Hispanic White TB patients from
this region of New York (Marks et al., 2019). The misconception about TB is also a risk
factor for acquiring the disease among non-Hispanic Whites. For instance, Howley et al.
(2015) and Pagaoa et al. (2015) argued that the belief of some non-Hispanic Whites in
having adequate TB knowledge to protect themselves from acquiring the disease is also a
risk factor for TB transmission in New York-Newark-Jersey City. However, finding the
risk factors for TB among non-Hispanic Asians is challenging in this area of New York.
The risk for a high burden of TB among non-Hispanic Asians is unclear in New
York-Newark-Jersey City. The non-Hispanic Asians are classified among the top four
ethnic groups of TB patients in this part of New York. However, their risk exposures to
this infectious disease are currently unclear. Klein, Harris, Leone, and Pettifor (2014) and
Stennis et al. (2015) found the non-Hispanic Asian TB patients to have constantly refused
to test for HIV, which is a common risk factor for TB in New York-Newark-Jersey City.
Consequently, such a low adherence to HIV testing among the non-Hispanic Asians led
Stennis et al. (2015) to say that HIV may be a contributing risk factor for the high burden
of TB among the non-Hispanic Asians in this area of New York. Besides the
race/ethnicity demographics, the gender difference is a contributing risk factor for the
incidence trends of TB in this district of New York.
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Gender differences also influenced the incidence of TB from 1993 to 2017 in
New York-Newark-Jersey City. In their studies, Katyal et al. (2018) and Stennis et al.
(2017) argued that the risks of unemployment, poverty, and co-HIV infection are
associated with more female TB patients than their male counterparts from this region in
New York. Similarly, Gounder et al. (2015) and Slutsker et al. (2017) indicated that the
female children, aged five and under are disproportionately affected by the resurgent
incidence of latent TB in this area of New York. Also, the age demographic has an
influence on the high burden of TB in New York-Newark-Jersey City.
TB has affected persons of all ages in New York-Newark-Jersey City. However,
identifying the most affected age group of TB patients has remained a controversial topic
in this area of New York City. From 2014 to 2017, children, aged five and under were
more vulnerable than older adults to acquiring the TB infection through contact with TB
patients in poor housings and communities in New York-Newark-Jersey City (Gounder et
al., 2015; Sanderson et al., 2015; Slutsker et al., 2017). Conversely, TB patients, aged
between 19 and 50 were more at risk of infecting with TB at work, schools, and by
interacting with other persons in New York-Newark-Jersey City (Howley et al., 2015;
Robbins, Shashkina, Kreiswirth, & Proops, 2017; Stennis et al., 2015).
Other researchers argued that the elderly community is disproportionately
affected by the incidence of TB in New York-Newark-Jersey City. The New York City
Department of Health and Mental Hygiene (2017) and Marks et al. (2014) argued that
older persons, aged 65 and older are mostly afflicted by TB from this region of New
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York City. Additionally, the elderly population has been afflicted by the multi-drug
resistant and mortality issues from this area in New York City (Marks et al., 2014; New
York City Department of Health and Mental Hygiene, 2017). The individuals’
race/ethnicity, age, and sex (gender) had influenced the escalation of TB incidence during
these past five years in New York-Newark-Jersey City.
Summary
The purpose of the review in Chapter 2 was to discuss the evidence related to the
incidence of TB for the past five years in New York-Newark-Jersey City. However, this
review focused mainly on finding the evidence related to the individuals’ race/ethnicity,
age, sex (gender), issues of therapy completion and drug susceptibility, and the TB
incident cases between 1993 and 2017 from this area in New York City.
Previous studies showed the relevance of gender and race/ethnicity demographics
to the elevated incident cases of TB in New York-Newark-Jersey City during 1993-2017.
However, the findings of these studies showed that the age demographic was the most
influential risk factor for exposing persons to TB from this region in New York City.
Importantly, the literature gap of this review was based on the relationship between TB
therapy completion, isoniazid and rifampin susceptibility, and the high TB incident cases
from this metropolitan area in New York. From a retrospective cohort study design, this
quantitative analysis study was conducted on the relationship between the individuals’
demographic characteristics, issues connected to TB therapy and drug susceptibility, and
the TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
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Chapter 3: Research Method
Introduction
The purpose of this quantitative study was to explore the relationship between
demographic characteristics of TB patients, therapy completion, isoniazid and rifampin
susceptibility, and the TB incident cases between 1993 and 2017 in New York-NewarkJersey City. Age, sex (gender), race/ethnicity, completion of therapy within one year, and
testing for isoniazid and rifampin susceptibility were the independent variables for this
study. The TB incident cases between 1993 and 2017 from this area in New York City
was the dependent variable for this research. Chapter 3 consists of the rationale for
conducting this TB research, methodology, threats to the validity of this study, and a
summary section.
Research Design and Rationale
This study was a quantitative analysis with a focus on a retrospective cohort
design. MacGill (2018) and Sedgwick (2014), and Setia (2016) indicated that a cohort
study may be designed as prospective or retrospective. Prospective or retrospective
designs were previously used in research to investigate the risk factors of a given
outcome during a long period of time in a large population (MacGill, 2018; Sedgwick,
2014; Setia, 2016). Using the retrospective cohort study design allowed me to investigate
whether race/ethnicity, age, sex (gender), completion of TB therapy within one year or
less, cases tested for susceptibility to isoniazid and rifampin were associated with the
elevated TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
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Both prospective and retrospective cohort study designs are crucial in evaluating whether
one or more variables are related to an event of interest.
The retrospective cohort design differs from a prospective design. A prospective
cohort study design is of value in conducting research from a population-based approach
to investigate the risk exposures for a particular outcome (MacGill, 2018; Sedgwick,
2014; Setia, 2016) argued that. In contrast, the retrospective cohort study is often used to
investigate whether a set of existing data is related to such an outcome in a given
population (MacGill, 2018; Sedgwick, 2014; Setia, 2016). Furthermore, a cohort study
design is critically important in investigating the increasing incidence rate of an event at a
specific location (Setia, 2016). As such, the retrospective study design was appropriate
for investigating if race/ethnicity and covariates, age and sex (gender), completion of
therapy within one year, and testing for isoniazid and rifampin susceptibility were
predictors of the TB incident cases in New York-Newark-Jersey City from 1993 to 2017.
There are disparities in time and cost for conducting a prospective or retrospective
cohort study. The cost of conducting a prospective cohort study is exorbitant and requires
a long time to complete (MacGill, 2018; Sedgwick, 2014; Setia, 2016). Contrarily, using
a retrospective study design was cost-efficient in previous studies, and required a shorter
time for analyzing a secondary dataset of an event from a population (Sedgwick, 2014;
Setia, 2016). This study was a quantitative analysis and was not subjected to time
constraints and high costs of using a prospective cohort study design.
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Using the retrospective cohort design strengthened the potential of this study for
advancing the knowledge in the TB research discipline. MacGill (2018) thought that a
retrospective study design is the finest method to be used for conducting medical research
involving the investigation of several predictors of an outcome in a given population.
Such a study design was previously used in both the non-experimental and experimental
research studies for investigating numerous risk factors in relation to one outcome at a
specific location (MacGill, 2018; Sedgwick, 2014; Setia, 2016). Additionally, the cohort
study design was previously credited for its effectiveness in conducting research within a
large population (MacGill, 2018; Sedgwick, 2014; Setia, 2016). Thus, the retrospective
cohort study design was feasible for investigating the relationship between the
individuals’ race/ethnicity, age, and sex (gender), and issues of therapy completion and
drug susceptibility in New York-Newark-Jersey City from 1993 to 2017. Also, a
retrospective cohort design is crucial for studies involving the evaluation of variables of
different scales of measurements.
Methodology
Study Population
This study is representative of the population of TB patients between 1993 and
2017 in New York-Newark-Jersey City. However, the disease population is subdivided
into the non-Hispanic American Indians or Alaskans Native, non-Hispanic Asians, nonHispanic Blacks, Hispanics, non-Hispanic Whites, and multiracial TB patients. To obtain
data for this study, the publicly available 1993-2017 TB dataset was used from the
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CDC’s online tuberculosis information system (OTIS). Prior to obtaining the above TB
dataset, a request was made to the institutional review board (IRB) of Walden University
about granting an exemption of ethical approval to access the data.
Upon receiving the permission from this institution (IRB number: 10-08-190399079), the data for the independent variables, race/ethnicity, age, sex (gender),
completion of therapy within one year, and testing for isoniazid and rifampin
susceptibility were obtained, as well as the dependent variable, cases of 672 TB cases
from 1993-2017 in New York-Newark-Jersey City. Notably, the CDC is reputed for
availing trustworthy public health data and information for other researchers to conduct
their own studies. Thus, the data obtained from the 1993-2017 TB dataset from this
agency was considered safe. The generalizability of this research was also based on the
demographic characteristics of its study population.
Both age and sex (gender) are known as the intrinsic risk factors for the incidence
of TB in a given population. However, the persons of a certain age and gender groups
were disproportionally affected by the incident cases of TB from 2011 to 2017 in New
York-Newark-Jersey City. Hence, in part, the purpose of this study was to investigate
whether age and sex (gender) demographics were predictors of the elevated TB incident
cases between 1993 and 2017 from this area in New York City. For that reason, I
included TB patients between the ages of 0-65 years and older, as they were reported in
the OTIS database. Additionally, estimating the sample size was equally important for
this TB research.
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Estimation of Sample Size
The sample size for this study was estimated using the G*Power statistical
analysis. Of this power analysis, there are several statistical tests available for the
statistical analyses of social, behavioral, and biomedical research studies (Faul, Erdfelder,
Buchner, & Lang, 2009). However, the z-tests and Poisson regression models were
selected for estimating the sample size, alpha, power, and effect size of this study. The
alpha level from the G*Power analysis was set to 0.05, allowing for a 5% probability of
error or type I error estimating the statistical values of this study.
Using the z-tests and Poisson regression model of the G*Power analysis, an
estimated sample size (N=128), along with the effect size of 0.8 and the actual power of
0.95 was suggested for conducting this study. Contrarily, the population of the TB
disease between 1993 and 2017 in New York-Newark-Jersey City was estimated to 672
patients (CDC, 2018). If an estimated sample (N=128) could result in an effect size of
0.8, the sample size (N=672) would be adequate to conduct this study. The Poisson
regression model could be of value in analyzing the data of this study.
Statistical Analytic Method
The dependent variable of a research study often informs the appropriate
statistical test for its analysis. Htway (n.d.) and Jackson (2016) indicated that the
dependent variable of a study is the determinant of the types of statistic tests required for
the data analysis of such a project. As such, the reported TB incident cases as the
dependent variable of this study were an indicator that the Poisson regression model
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could be appropriate for analyzing this data. However, the Poisson regression model has
various assumptions.
Like many other statistical tests, the Poison regression model has its own
assumptions. Such a statistic test assumes the dependent variable of a research study is
continuous and contains counted data (Laerd Statistics, n.d.; University of California, Los
Angeles (UCLA), Institute for Digital Research & Education, n.d.). As such, the
dependent variable, reported TB cases, is a continuous variable with counted data.
Conversely, the independent variables of a Poisson analysis may be varied in categorical,
continuous, or interval ratio variables (Laerd Statistics, n.d.; UCLA, Institute for Digital
Research & Education, n.d.). The independent variables of this research were of different
scales of measurements.
Of this study, the independent variables were mixed with the categorical
variables, race/ethnicity, and sex and continuous variables, completion of therapy within
one year, testing for isoniazid and rifampicin susceptibility, and age. Grande (2015),
Laerd Statistics (n.d.), UCLA, Institute for Digital Research & Education (n.d.), and Zedstatistics (2017) indicated that the Poisson regression model has required the independent
observation across the predictors of an outcome at a given time. Moreover, the mean and
variance of the Poisson distribution must be similar (Grande, 2015; Laerd Statistics, n.d.;
Zed-statistics, 2017). It is worthwhile noting that, the threats to the validity of this
research are minimal.
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Threats to Validity
The threats to the validity of a research study often determine the generalizability
of findings in such a study. Featherston (2015) and Froehlich (2015) indicated that the
threats to the validity of a study are often based on internal or external sources. From this
study, the threats to the validity of its findings could come from external sources.
However, such threats were minimal because the 1993-2017 TB dataset has been
collected and organized by the CDC agency in 2018.
As previously indicated, the CDC agency is trustworthy, with a great reputation in
collecting health data for public use. Thus, obtaining the above dataset of the CDC’s
website assured a minimal external threat to the validity of findings from this study.
Importantly, this research was not associated with internal validity threats. Featherston
(2015) and Froehlich (2015) also indicated that such threats are often associated with
instrumentation, history, maturation, and selection bias of a prospective research study.
Since this study was conducted from a quantitative approach, its findings could not be
subjected to internal validity threats.
As indicated above, the usage of instrumentation is appropriate in a qualitative
research study. However, this study was a quantitative analysis of a secondary dataset,
and thus, was exempt from using instrumentation. Consequently, the threats associated
with using the instrumentation could not affect the validity of findings from this TB
research in New York-Newark-Jersey City.
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Ethical Concerns and Data Collection
To use an archival dataset, researchers must provide information on how they
were collected. As such, the CDC (2018) indicated that the 1993-2017 TB dataset is a
combination of data from TB patients reported by the departments of health from the
district of Columbia and Puerto Rico of the United States (CDC, 2018). Upon receiving
the data of TB patients from these health agencies, the CDC organized them into 28
variables (CDC, 2018). Additionally, this agency has regularly updated and availed these
data on a yearly basis for public use (CDC, 2018). However, researchers are required to
be ethical in collecting and using data for their studies.
Often, researchers are subjected to unethical research behaviors collecting and
using data in their studies. Likewise, using the 1993-2017 TB dataset for the population
of TB patients in New York-Newark-Jersey City did not exempt me from such an
unethical threat. However, such a threat was minimal because I was not involved in
collecting data of TB patients during this period. As previously indicated, I was obligated
by the IRB of Walden University to ask for permission to access the 1993-2017 TB data
set. Thus, I requested permission from the IRB of the above institution, and I was granted
the opportunity to obtain this data set from the OTIS database of the CDC agency.
Using the information study participants for other purposes than what they were
collected for is an unethical research practice. Such behavior of some researchers may be
seen in using the information of their study participants for reasons other than what they
purported to be used for (United States Department of Health and Services, n.d.). This
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unethical research practice may be observed in collecting data from human subjects in
either an intervention or an observational study in which the researchers violate the
privacy of their study participants (United States Department of Health and Services,
n.d.). However, I used the existing 1993-2017 TB dataset solely for the purpose of
completing my dissertation research at Walden University. Additionally, some
researchers may be subjected to unethical behavior in publishing the findings from their
studies.
Exposing sensitive information of study participants to the public without their
consent is another form of unethical research practice. Often, such behavior of some
researchers is seen in publishing the names, medical records, and date of births of their
study participants without informing them (United States Department of Health and
Services, n.d.). However, the above sensitive information of TB patients in New YorkNewark-Jersey City was not included in the 193-2017 TB dataset, and thus, was not
included in the data analysis of this study. Therefore, the publication of this dissertation
research will not contain the sensitive information of TB patients listed above.
Summary
The purpose of this study was to investigate the relationship between
demographic characteristics of TB patients, issues of TB therapy completion and drug
susceptibility, and the TB incident cases between 1993 and 2017 in New York-NewarkJersey City. As previously indicated, this quantitative analysis was based on a
retrospective cohort study design. Chapter three of the dissertation provided the evidence
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showing the applicability of the retrospective cohort study design investigating several
risk factors of an outcome of interest in a population for a long period of time. As such,
this study design was appropriate in exploring the relationship between the individuals’
race/ethnicity, age, sex, and issues of therapy completion and isoniazid and rifampin
susceptibility, and the TB incident cases in New York-Newark-Jersey City from 1993 to
2017.
In Chapter 3, I presented the rationale for conducting this study. Additionally, it
was included evidence on the feasibility of the Poisson regression model for analyzing
the data of this study. Furthermore, I provided a section wherein the explanation about
the minimal external threats of this study was provided. Additionally, Chapter 3 included
a description of the procedure under which the 1993-2017 TB data set was obtained from
the CDC agency.
Chapter 4: Study Results
Introduction
The purpose of this study was to investigate whether race/ethnicity, age, sex
(gender), completion of therapy within one year, and testing for isoniazid and rifampin
susceptibility were predictors of the TB incident cases in New York-Newark-Jersey City
from 1993 to 2017. These variables were used to formulate the research questions and
hypotheses of this study. A reasonable research question and hypothesis is one that
attempts to identify the population of a research study (Farrugia, Petrisor, Farrokhyar, &
Bhandari (2010). As such, the research questions and hypotheses from this research were

62
formulated by questioning whether the individuals’ race/ethnicity, age, and sex (gender)
were associated with the incident cases of TB in New York-Newark-Jersey City during
1993-2017.
This study was also conducted by formulating other research questions and
hypotheses, which interrogated whether the issues of therapy completion and isoniazid
and rifampin susceptibility were predictors of the TB incident cases between 1993 and
2017 from this region in New York City. These research questions and hypotheses were
formulated to investigate the incidence of TB between 1993 and 1997 in New YorkNewark-Jersey City.
RQ1. Is there a relationship between race/ethnicity and covariates (age and sex),
and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey City?
H0 1. There is no relationship between race/ethnicity and covariates (age and sex),
and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
H1 1. There is a relationship between race/ethnicity and covariates (age and sex),
and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
RQ2. Is there a predictive relationship between the completion of therapy within
one year and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey
City?
H0 2. There is no predictive relationship between the completion of therapy within
one year and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey
City.
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H1 2. There is a predictive between completion of therapy within one year and the
TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
RQ3. Is there a predictive relationship between the cases that tested for isoniazid
and rifampin susceptibility to the TB incident cases between 1993 and 2017 in New
York-Newark-Jersey City?
H0 3. There is no predictive relationship between the cases that tested for
isoniazid and rifampin susceptibility to the TB incident cases between 1993 and 2017 in
New York-Newark-Jersey City.
H1 3. There is a predictive relationship between the cases that tested for isoniazid
& rifampin susceptibility and the TB incident cases between 1993 and 2017 in New
York-Newark-Jersey City.
In Chapter 4, I discuss the procedure required to obtain the 1993-2017 TB dataset.
However, the main purpose of this chapter is to show the results, demonstrating whether
the individuals’ race/ethnicity, age, sex (gender), completion of therapy within one year,
and testing for isoniazid and rifampicin susceptibility were predictors of the TB incident
cases between 1993 and 2017 in New York-Newark-Jersey City. This study was
conducted by using a secondary data set of TB representing this infectious disease’s
population in New York-Newark-Jersey City. In this chapter, I discuss the statistical
results pertaining to the relationships between the independent and dependent variables of
this study.
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Data Collection
This study was a quantitative analysis of a secondary dataset. Therefore,
collecting data directly from TB patients in New York-Newark-Jersey City was not an
option for this research. As such, this study was conducted by using data from the
publicly available 1993-2017 TB dataset from the CDC’s OTIS database. The TB data
were organized for TB patients from the 50 states and metropolitan areas in the United
States within the OTIS database (CDC, 2018). This database is a subsidiary site of the
wide-ranging data online for epidemiological research (WONDER) from which the
information about the TB dataset was made available for the public use (CDC, 2018).
Therefore, using the data of TB patients from the TB data set exempted me from the
discrepancies in collecting data directly from the TB patients in New York-NewarkJersey City during 1993-2017.
Determining the arrangement of this data set was crucial for conducting this TB
research. To learn about how these data were arranged, I explored the OTIS website,
which informed me about the organization of the 1993-2017 TB data set for New YorkNewark-Jersey City. From this website, I learned about the data of TB patients that were
arranged by groups, such as the individuals’ race/ethnicity, sex (gender), and age groups
from 1993 to 2017 (see CDC, 2018). The OTIS database included a variety of risk
factors, disease criteria, and issues related to the incident cases of TB across the United
States, including New York-Newark-Jersey City (see CDC, 2018). The OTIS database
contained the variables that I was interested in for this study.
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From the OTIS database, I obtained the independent variables, race/ethnicity, age,
sex (gender), completion of therapy within one year, testing for isoniazid and rifampicin
susceptibility, and cases of TB from 1993-2017 in New York-Newark-Jersey City. Prior
to accessing the 1993-2017 TB data set, CDC agency I contacted asking for its
permission to use the TB data set for this research. In response, a member of this agency
replied by informing that the 1993-2017 TB dataset was and continued to be available for
the public use. Therefore, I accessed this data set and obtained data regarding the
independent and dependent variables of this study. However, I was concerned that using
this data set might harm the validity of this data due to a minimal external threat issue.
External validity threats can efface the generalizability of a quantitative research
study. More specifically, external threats represent a challenge in interpreting the findings
of a quantitative research study (Featherston, 2015; Froehlich, 2015; Grande, 2014). Such
threats are often associated with selecting the participants of a study based on the
individuals’ race/ethnicity, which is a selection bias (Featherston, 2015; Froehlich, 2015).
Consequently, the generalizability of findings from this study may not be representative
of its study population (see Featherston, 2015; Froehlich, 2015).
In this study, the sample included individuals of all ethnic backgrounds, including
American Indian, Asian, Black, Hispanic, Multi-racial, Native Hawaiian, and White TB
patients between 1993 and 2017 in New York-Newark-Jersey City. Consequently, the
exclusion of study participants based on their race/ethnicity was not a threat to the
generalizability of findings in this TB research. However, other demographic
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characteristics could represent a threat to the validity of a research study. In this study,
both age and sex (gender) demographics were evaluated to prevent such a validity threat
from affecting the generalizability of this study. Featherston (2015) and Froehlich (2015)
argued that conducting a study with participants of a limited age or gender group may not
be representative of some other age and sex (gender) groups of a study population.
However, such a selection bias was not associated with this study because its sample
included both male and female TB patients, aged between 0-65 years and older in New
York-Newark-Jersey City.
The size of the sample from a study may also represent a threat to its validity of
findings. Froehlich (2015) and Grande (2014) indicated that the sample size of
quantitative research can represent a burden for the validity of the findings of a study.
However, such an external threat is often associated with a quantitative research study
with an inadequate sample size to represent its population (Froehlich, 2015; Grande,
2014). This study involved the investigation of 672 TB patients, and thus, was adequate
to represent the population of the TB disease between 1993 and 2017 in New YorkNewark-Jersey City.
The participants of this study accumulated an estimated 46,512 TB incident cases
from 1993 to 2017 in New York-Newark-Jersey City. Of these cases, 27,926 cases
completed therapy within one year or less, and 20,264 cases were associated with the
issue of isoniazid and rifampin susceptibility during this period. Notably, these TB
incident cases were ethnically subdivided among the American Indians, Asians, Blacks,

67
Hispanics, Multi-racial, Native Hawaiians, Whites, and other unidentified ethnic groups
in New York-Newark-Jersey City (CDC, 2018). Also, analyzing the 1993-2017 TB data
set required the creation of an SPSS data set.
Transfer of Data into the IBM-SPSS, Version 25
The data obtained from the OTIS database were entered into the SPSS version 25
using a password-protected computer for the safety of these data. Additionally, the newly
created SPSS TB data set was saved into a flash drive and placed in a secured location.
As previously indicated, this study involved in predicting whether the individuals’
race/ethnicity, age, and sex (gender), and completion of therapy within one year, and
isoniazid and rifampin susceptibility were related to the TB incident cases between 1993
and 2017 in New York-Newark-Jersey City.
Some of these predictors were string variables. However, the SPSS software
would not analyze the data that were associated with these string variables. Consequently,
the independent variable, such as completion of therapy within one year was converted
into COT for the ease of data analysis on SPSS. Likewise, the tested for isoniazid and
rifampin susceptibility variable was converted into TIRS allowing the SPSS software to
analyze its data. However, some other demographic variables were not changed into
acronyms from the OTIS database.
The age demographic has been reported as it was within the OTIS database, and
thus, was entered as such into SPSS. The data of the sex variable, however, could not be
analyzed using SPSS. Consequently, the sex (gender) demographic was changed into
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r@sex allowing for its data to be analyzed on SPSS. The race/ethnicity variable had not
changed to an acronym in the OTIS database. However, the SPSS software could not
analyze the data that were associated with the individuals’ race/ethnicity
The race/ethnicity variable was converted into race.eth_cat allowing the SPSS
software to analyze its data. Additionally, the SPSS could not analyze the data of the
reported TB incident cases, which was the dependent variable of this study. Therefore,
this variable was changed into TBcases@1993.2017 easing the analysis using SPSS
software. Notably, the SPSS software is accustomed to analyzing the numerical data.
Therefore, the variables from this study were coded with various numerical values.
As previously indicated, the OTIS database had organized the data of TB patients
by their ethnicities (e.g., American Indian or Alaska Native, non-Hispanic, Asian, nonHispanic, Black or African American, non-Hispanic, Hispanic or Latino, Whites, nonHispanic, multiple race, non-Hispanic, Native Hawaiian or Other Pacific Islander, nonHispanic, and the not reported racial and ethnic groups). Using the SPSS software, the
non-Hispanic White was coded as 0, non-Hispanic Black or African American was coded
as 1, Hispanic or Latino was coded as 2, non-Hispanic Asian was coded as 3, nonHispanic Multi-racial were coded as 4, Native Hawaiian or Other Pacific Islander, nonHispanic was coded as 5, American Indian or Alaska Native, non-Hispanic was coded as
6, and the not reported race/ethnicity group was coded as 99. The individuals’ age groups
were also coded with some numerical values in this study.
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From the OTIS database, the individuals’ ages were organized into several
groups, such as 0-4 years, 5-14 years, 15-24 years, 25-44 years, 45-64 years, 65+ years,
and not reported. However, when entered into the SPSS software, the 0-4 years group
was coded as 1, 5-14years group was coded as 2, 15-24 years group was coded as 3, 2544 years group was coded as 4, 45-64years group was coded as 5, 65+years group was
coded as 6, and not reported age group was coded as 99. Likewise, the sex demographic
was coded with some numerical values.
The TB incident cases were organized by the individuals’ sex (gender) (e.g., male,
female, or not reported sex) in the OTIS database. Therefore, when entered into the SPSS
software, the male group was coded as 1, the female group was coded as 0, and the not
reported sex group was coded as 99. Contrarily, the cases of therapy completion within
one year and tested for isoniazid and rifampin susceptibility were coded differently in the
OTIS database.
As previously indicated, the completion of therapy (COT) within one year was
one of the string variables of this study. Importantly, this variable was used for measuring
the numbers and percentages of TB incident cases that completed therapy within one year
or less (CDC, 2018). Therefore, the data of the COT cases were coded as no, yes, not
reported, not applicable. Contrarily, when entered into the SPSS software, no was coded
as 2, yes was coded as 1, not reported was coded as 99, and not applicable was coded as
999.
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The CDC agency began organizing the TB incident cases, with isoniazid and
rifampin susceptibility from 2005 to the present time in the OTIS database (CDC, 2018).
Additionally, this agency organized the incident cases, with susceptibility to isoniazid
and rifampin as no, yes, not applicable. When entered into SPSS, the no cases were coded
as 0, yes cases were coded as 1, and not applicable cases were coded as 999. Also, the
missing data represented a challenge to analyze the data of this study.
There have been missing data reported in the 1993-2017 TB dataset. The missing
values were associated with the tested for isoniazid and rifampin (TIRS) variable and
were estimated to 168 incident cases. Likewise, an estimated 68 incident cases of TB
have not been reported between 1993 and 2017 in New York-Newark-Jersey City.
However, the not reported, not applicable, and missing data were treated similarly.
Both the independent and dependent variables of this study had contained either
the not reported, not applicable, or missing data. Under the variable view of the created
SPSS data set, the not reported and not applicable data were coded as 99 and 999,
respectively. However, they have been treated as missing data while analyzing the
variables they were associated with using the SPSS software.
From the OTIS database, the individuals’ ages were organized into several
groups, such as 0-4 years, 5-14 years, 15-24 years, 25-44 years, 45-64 years, 65+ years,
and not reported. However, when entered into the SPSS software, the 0-4 years group
was coded as 1, 5-14years group was coded as 2, 15-24 years group was coded as 3, 2544 years group was coded as 4, 45-64years group was coded as 5, 65+years group was
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coded as 6, and not reported age group was coded as 99. Likewise, the sex (gender)
demographic was coded with some numerical values.
The TB incident cases were organized by the individuals’ sex (gender) (e.g., male,
female, or not reported sex) in the OTIS database. Therefore, when entered into the SPSS
software, the male group was coded as 1, the female group was coded as 0, and the not
reported sex group was coded as 99. Contrarily, the cases of therapy completion within
one year and tested for isoniazid and rifampin susceptibility were coded differently in the
OTIS database.
As previously indicated, the completion of therapy (COT) within one year was
one of the string variables of this study. Importantly, this variable was used for measuring
the numbers and percentages of TB incident cases that completed therapy within one year
or less (CDC, 2018). Therefore, the data of the COT cases were coded as no, yes, not
reported, not applicable. Contrarily, when entered into the SPSS software, no was coded
as 2, yes was coded as 1, not reported was coded as 99, and not applicable was coded as
999.
The CDC agency began organizing the TB incident cases, with isoniazid and
rifampin susceptibility from 2005 to the present time in the OTIS database (CDC, 2018).
Additionally, this agency organized the incident cases, with susceptibility to isoniazid
and rifampin as no, yes, not applicable. When entered into SPSS, the no cases were coded
as 0, yes cases were coded as 1, and not applicable cases were coded as 999. Also, the
missing data represented a challenge to analyze the data of this study.
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There have been missing data reported in the 1993-2017 TB dataset. The missing
values were associated with the tested for isoniazid and rifampin (TIRS) variable and
were estimated to 168 incident cases. Likewise, an estimated 68 incident cases of TB
have not been reported between 1993 and 2017 in New York-Newark-Jersey City.
However, the not reported, not applicable, and missing data were treated similarly.
Both the independent and dependent variables of this study had contained either
the not reported, not applicable, or missing data. Under the variable view of the created
PSS data set, the not reported and not applicable data were coded as 99 and 999,
respectively. However, they have been treated as missing data while analyzing the
variables they were associated with using the SPSS software.
Data Analysis and Results
As proposed in the methodology section of this research, the Poisson regression
model could be of value in the data analysis for this study. Therefore, this statistic test
was utilized to analyze whether the race/ethnicity, age, and sex(gender) demographics,
completion of therapy within one year, and testing for isoniazid and rifampin were
predictors of the TB incident cases between 1993 and 2017 in New York-Newark-Jersey
City.
Prior to conducting this data analysis, the dependent variable (e.g., reported
tuberculosis case) was tested for the equality of the mean and variance using the Poisson
regression model. As part of the assumptions from this static test, the dependent variable
of a research study must include counted data of which the mean and variance ought to be
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equal or similar (UCLA, Institute for Digital Research & Education, n.d.). However,
Grace-Martin (n.d.) indicated that such an assumption is commonly violated using the
Poisson regression model. Therefore, the violation of equal statistical value between the
mean and variance couldn’t affect the results from the data analysis of this study.
Consequently, the Poisson regression model was used to individually analyze the
variables from the three research questions of this study.
The Poisson regression was the best model for this quantitative analysis study.
The UCLA, Institute for Digital Research & Education (n.d.) noted that the effectiveness
of the Poisson regression is based on its provisions of the statistically significant p-values
and the exponentiated coefficients showing a positive relationship between a predicting
variable with outcome variable in a research study. The above static values could be of
value in responding to the hypotheses of a research study.
As such, the above statistical values were used to decide about the hypotheses of
this dissertation research. The UCLA, Institute for Digital Research & Education (n.d.)
also commented on these statistics by indicating that the coefficient and p-values of the
Poisson regression analysis were often used in previous researches for deciding whether
to accept or reject the null hypothesis in favor of the alternative one of a particular
research question (UCLA, Institute for Digital Research & Education, n.d.). As such, the
statistically significant p-values and exponentiated coefficients were crucial in showing
the relationship between the individuals’ race/ethnicity, age, sex (gender), issues of
therapy completion and isoniazid and rifampin susceptibility, and the reported TB
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incident cases in New York-Newark-Jersey City from 1993 to 2017. Based on the results
from the above analysis, the null hypotheses of this research were rejected in favor of the
alternative hypotheses.
As previously indicated, the probability distribution is commonly violated in the
Poisson regression model. As such in Table 1, the descriptive statistics showed that the
dependent variable reported tuberculosis cases violated this assumption. However, the
Omnibus test of this analysis had shown the likelihood of all predicting variables to
improve the Poisson regression model.
Table 1
Descriptive Statistics Between the Independent and Dependent Variables of the Study
N

Mean

Reported tuberculosis cases

604

77.0066

Valid N (list wise)

604

Variance
60996.832

The Omnibus test is often seen as a gatekeeper by indicating the next step of the
Poisson regression analysis. As such, it is critically important for investigating and
revealing the likelihood of various predicting variables to improve the above model over
the intercept (UCLA, Institute for Digital Research & Education, n.d.). Consequently, the
race/ethnicity, age, sex (gender), COT, and TIRS predicting variables of this study were
added into one model for testing their likelihood to improve the Poisson regression
model. As a result, the Omnibus test of the Poisson regression analysis displayed a

75
significant p < 0.001 indicating a statistically significant model. Therefore, the data
analysis of this study proceeded by analyzing each of the above predicting variables
against the outcome variable reported tuberculosis cases.
Research Question 1 and Hypotheses
The first research question of this study addressed the issue of whether
race/ethnicity and covariates, age and sex (gender) are were related to the TB incident
cases between 1993 and 2017 in New York-Newark-Jersey City. Therefore, using the
SPSS software, race/ethnicity, age, and sex (gender) were modeled as predictors of the
response variable, reported TB incident cases using the Poisson regression test.
To analyze the above variables, the statistics feature of the generalized linear
model was selected and yielded the following results in Tables 2, 3, 4, 5, 6, 7, 8, and 9.
Also, it was worth noting that the Poisson regression model was useful in demonstrating
the likelihood or probability distribution of data that were associated with the dependent
variable, reported tuberculosis cases. Additionally, this model was also informative by
showing the likelihood of the above-predicting variables to be analyzed against the
dependent variable via the natural logarithm function. Thus, these findings bellow were
integral in deciding whether to accept or reject the null hypothesis of research question
number one.
In Table 2, the Poisson regression model displayed the case processing summary
of the reported tuberculosis cases. This table showed an estimated 672 TB incident cases
that were reported between 1993 and 2017 in New York-Newark-Jersey City. Of these,
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385 (57.3%) cases were excluded and 287 (42.7%) other cases were included in this
analysis. Importantly, the excluded TB incident cases were determined based on the
unreported, not applicable, and missing data in the OTIS database for New YorkNewark-Jersey City from 1993 to 2017.
Table 2
The Descriptive Statistics Showing the Included and Excluded Tuberculosis Incident
Cases from this Study.

Included

N
287

Percent
42.7%

Excluded

385

57.3%

Total

672

100.0%

In Table 3, the Poisson regression analysis showed the numbers and percentages
of ethnic groups that were attributed to the incident cases of TB between 1993 and 2017
in New York-Newark-Jersey City. Additionally, this analysis showed that race/ethnicity
risk factor was a categorical variable for the reported tuberculosis cases during this
period.
This statistic test had also demonstrated the ethnic distributions of TB among 287
patients from this area in New York City during this period above. Of 287 TB patients,
there were 42 (14.6%) Asians, 47 (16.4%) Blacks, 47 (16.4%) Hispanics or Latinos, 31
(10.8%) Multi-racial, 37 (12.9%) Whites, 40 (13. (%) Native Hawaiians, and 43 (15.0%)
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American Indian or Alaskan Native in New York- Newark-Jersey City from 1993 to
2017.
Table 3
The Descriptive Statistics Showing the Distribution of Tuberculosis Incident Cases
Across the Individuals’ Race/Ethnicity

Factor Race/Ethnicity

American Indian or Alaska Native

N
43

Percent
15.0%

Native Hawaiians

40

13.9%

MULTR

31

10.8%

Asians

42

14.6%

Hispanics

47

16.4%

Blacks

47

16.4%

Whites

37

12.9%

Total

287

100.0%

In Table 4, the Poisson regression model had treated both age and sex as the
continuous variables of this research. Additionally, this statistic test had shown the
distribution of data from the dependent variable were overdispersed. More importantly,
this table contained descriptive statistics pertaining to the above continuous variables.
From this analysis, there were 287 TB incident cases, along with a mean of 160.1603 and
a standard deviation of 339.59037. Of these incident cases of TB, the individuals’
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average age was estimated to 3.5575, with a standard deviation of 1.68996. Despite
treated as a continuous variable in this analysis, the individuals’ sex (gender) was
commonly known as a categorical variable. Therefore, interpreting the statistics
associated with this variable was unnecessary.
Table 4
The Descriptive Statistics About Age, Sex, and the Reported Tuberculosis Incident Cases

Dependent

Reported

Variable

Tuberculosis Cases

Covariate

Reported Age in

N Minimum Maximum Mean
287
.00
2417.00 160.1603

Std.
Deviation
339.59037

287

1.00

6.00

3.5575

1.68996

287

.00

1.00

.4948

.50085

Years
Reported Sex

From this analysis, the Omnibus test had demonstrated the likelihood of
race/ethnicity, age, and sex or gender variables to improve the Poisson regression model,
excluding the dependent variable of this study. Specifically, adding the above predicting
variables to this model resulted in a p < 0.001 indicating a statistically significant model.
In Table 5, the Poisson regression test had displayed the tests of model effects,
with a statistically significant p < 0.001 indicating a positive relationship between the
individuals’ race/ethnicity, age, sex (gender), and the reported TB incident cases between
1993 and 2017 in New York-Newark-Jersey City. In other words, this statistic test had
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revealed the overall effects of the above predictors on the incident cases of TB from this
area in New York City during 1993-2017.
Table 5
Tests of Model Effects of Race/Ethnicity, Age, and Sex Against the Reported Tuberculosis
Cases

Source
(Intercept)

Type III
Wald Chi-Square
df
956.305
1

Sig.
.000

Race/Ethnicity

5628.511

5

.000

Reported Age in Years

8245.448

1

.000

Reported Sex (gender)

2128.613

1

.000

The analysis in Table 6 was critical for responding to the hypotheses of research
question one. In this analysis, the parameter estimates had displayed the statistically
significant p-values and coefficients necessary for indicating whether the race/ethnicity,
age, and sex variables were predictors of the dependent variable, reported tuberculosis
cases in New York-Newark-Jersey City.
Table 6
Parameter Estimates Showing the Effects of the Race/Ethnicity, Age, and Sex (Gender)
Variables on the Reported Tuberculosis Cases Using Poisson Regression Model
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Parameter
B
Sig. Exp(B)
(Intercept)
3.583 .000 35.969
American Indian or Alaska Native, 36.445a . 1.487Enon-Hispanic
16

95% Wald Confidence
Interval for Exp(B)
Lower
Upper
34.570
37.425
.000
.000

Native Hawaiian or Other Pacific
Islander, non-Hispanic

-6.771 .000

.001

.001

.003

Multi-racial, non-Hispanic

-3.681 .000

.025

.021

.031

Asian, non-Hispanic

.610 .000

1.840

1.782

1.899

Hispanic or Latino

.739 .000

2.095

2.031

2.161

Black or African American, nonHispanic

.891 .000

2.437

2.364

2.512

.

1

.

.

Reported Age in Years

.277 .000

1.319

1.311

1.327

Reported Sex (gender)

.441 .000

1.555

1.526

1.584

White, non-Hispanic

(Scale)

0b

1c
As previously indicated, the Poisson regression model had displayed the

unstandardized coefficients “B”, exponentiated coefficients “Exp(B), and p-values
necessary to understand the relationship between the individuals’ race/ethnicity, age, sex,
and reported tuberculosis cases in New York-Newark-Jersey City from 1993 to 2017.
Often, researchers are relying on the resulting Exp (B) and p-values from the parameter
estimate in Poisson regression analysis for deciding whether to accept or reject the null
hypothesis of their research studies (The UCLA, Institute for Digital Research &
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Education, n.d.). As such, these statistical values must be used in deciding whether to
accept or reject the null hypothesis in research question one.
Using Multi-racial as the reference category in Table 7, the Poisson regression
model displayed the ethnic distribution of TB among the American Indians or Alaskans,
Asians, Blacks, Hispanics, Native Hawaiians, and Whites in New York-Newark-Jersey
City from 1993 to 2017. In this analysis, the “Exp(B)” and p-values were considered for
evaluating the effects of the above ethnic groups on the incident cases of TB from this
region in New York City during this period.
From Table 6, the Poisson regression analysis showed that Blacks, Hispanics, and
Asians were approximately 2.4 (95% Cl, 2.364 to 2.512 p < 0.001), 2.1 (95% Cl, 2. 031
to 2.161; p < 0.001), 1.8 (95% Cl, 1.782 to 1.899; p < 0.001) times more likely to be
contributed to the incident cases of TB, respectively between 1993 and 2017 in New
York-Newark-Jersey City. Additionally, the Multi-racial and Native Hawaiian ethnic
groups were correspondingly 0.025 (95%Cl, 0.021 to 0. 031; p < 0.001) and 0.001 (95%
CL,0.001 to 0.003; p < 0.001) times as likely to contribute to the above incident cases of
TB during this period in New York-Newark-Jersey City.
In this analysis, the individuals’ age and sex (gender) were found to be 1.32 (95%
Cl, 1.311 to 1.327; p < 0.001) and 1.56 (95%Cl, 1.526 to 1. 584; p < 0.001) times as
likely to influence the incident cases of TB in New York-Newark-Jersey City from 1993
to 2017. However, it was worthwhile knowing about which sex (gender) group was
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disproportionately affected by the above incident cases of TB from this area in New York
City.
From Table 7, the predicted log count of TB incident cases for males was
estimated to 1.58 (95%Cl, 1.554 to 1.613, p < 0.001). This indicated that the male TB
patients were 1.58 times more likely than their female counterparts to be infected with
TB between 1993 and 2017 in New York-Newark-Jersey City.
Table 7
Parameter Estimates Showing Males at a Disadvantage in Attributing to the Reported
Tuberculosis Cases
95% Wald Confidence
Interval for Exp(B)
Parameter
(Intercept)

B
4.552

Sig.
.000

Exp(B)
94.864

Males

.460

.000

1.584

Females

0a

Scale

1b

.

1

Lower
93.493

Upper
96.255

1.554

1.613

.

.

In Table 8, the Poisson regression model had shown the disparity in TB
attributions among male and female patients in New York-Newark-Jersey City from 1993
to 2017. In this analysis, there were 188 (49.5%) male and 192 (50.5%) female
contributors to the incident cases of TB from this area in New York City during this
period.
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Table 8
The Descriptive Statistics Showing the Gender Disparity in Attributing to the TB Incident
Cases
N
Factor

Reported Sex

Percent

Male

188

49.5%

Female

192

50.5%

Total

380

100.0%

Likewise, in table 9, the Poisson regression model had displayed the age
distribution of the incident cases of TB between 1993 and 2017 in New York-NewarkJersey City. With the age group 1 (e.g., 0-4 years) being considered as the reference
category, the Poisson regression analysis had shown that the persons of all age groups,
regardless of their ethnicities, were affected by the incident cases of TB during this
period in New York-Newark-Jersey City. However, there was heterogeneity in the
distribution of TB across the individuals’ age groups between 1993 and 2017 from this
area of New York City.
Table 9
Parameter Estimates Showing the Effect of Age on the Reported Tuberculosis Cases Using
the Poisson Regression Model
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95% Wald Confidence
Interval for Exp(B)
Exp(
B)
Lower
Upper
14.975
14.145
15.853

Parameter
(Intercept)

B
2.706

Sig.
.000

65 years of age and older

1.785

.000

5.959

5.605

6.335

45-64 years of age

2.246

.000

9.454

8.906

10.035

25-44 years of age

2.679

.000

14.576

13.746

15.457

15-24 years of age

1.251

.000

3.493

3.277

3.722

5-14 years of age

-.155

.000

.856

.787

.931

.

.

0-4 years of age

0b . . . . .

(Scale)

1c

.

1

In Table 9, the adult TB patients were afflicted by the incident cases of TB in
New York-Newark-Jersey City from 1993 to 2017. Looking at this table, it had shown
that the age groups 4 (i.e., 25-44 years), 5 (i.e., 45-64 years), 6 (i.e., 65= years), 3 (i.e.,
15-24 years) were 14.58 ( 95%Cl, 13.746 to 15.457, p < 0.001), 9.45 (95%Cl, 8.906 to
10.035, p < 0.001), 5.959 ( 95%Cl, 5.605 to 6.335, p < 0.001), 3.493 (95%Cl, 3.277 to 3.
722, p < 0.001) times more likely to influence the above TB incident cases in New YorkNewark-Jersey City during this period above. Additionally, this analysis revealed that the
persons, aged between 5 and 14 years old were approximately 0.86 (95%Cl, 0.787 to
0.931, p < 0.001) times as likely to be contributed to the incident cases of TB in New
York-Newark-Jersey City from 1993 to 2017.
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Based on the statistically significant p < 0.001 of each predicting variable in
research question one, it was likely to say that the individuals’ race/ethnicity, age, and
sex were strong predictors of the incident cases of TB in New York-Newark-Jersey City
from 1993 to 2017. Using the above statistical results, the null hypothesis of research
question one was rejected in favor of the alternative hypothesis indicating that there was a
relationship between the individuals’ race/ethnicity, age, sex, and the incident cases of
TB during 1993-2017 in New York-Newark-Jersey City.
The Poisson regression test also involved the analysis of the COT in relation to
the reported tuberculosis cases, which is the dependent variable of this study.
Consequently, the results of this analysis were used for deciding about the hypotheses in
research question two.
Research Question 2 and Hypotheses
The second research question was formulated about whether the COT was related
to the TB incident cases between 1993 and 2017 in New York-Newark-Jersey City. Such
a variable was used for measuring the percentage of patients that completed their TB
therapy within one year or less during this period in New York-Newark-Jersey City
(CDC, 2018). As a reminder, the COT variable was coded as 2 for no, 1 for yes, 99 for
not reported, and 999 for not applicable within the created SPSS data set. However, using
the Poisson regression model, the 99 and 999 were excluded and treated as missing
values in this analysis.
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Evaluating the effect of COT on the reported TB cases was done through the
parameter estimates of the Poisson regression model. However, other analyses, such as
the case processing information, distribution of both the categorical and continuous
variables, Omnibus test, and model effect tests were also useful in understanding the
significance of COT in impacting the incident cases of TB in New York-Newark-Jersey
City from 1993 to 2017.
Looking at Table 10, the Poisson regression model showed the numbers and
percentages of cases that completed therapy within one year or less (COT). In this
analysis, the COT was also considered as a categorical variable. In Table 10, there was an
estimated sample of 305 TB patients, 149 (48.9%) did not complete therapy within one
year or less. Conversely, 156 (51.5%) participants of the above sample completed their
therapy within one year or less in New York-Newark-Jersey City from 1993 to 2017.
Table 10
Descriptive Statistics Showing the Estimated Numbers of Cases that Completed Therapy
Within One Year

Factor

Completion of Therapy
within One Year

N

Percent

Not Completed Therapy
within One Year

149

48.9%

Yes, Completed Therapy
Within One Year
Total

156

51.1%

305

100.0%

87
From Table 11, the Poisson regression model exhibited the numbers of included
and excluded cases of TB in this analysis. Of 672 TB incident cases, 305 (45.4%) cases
included in therapy completion and 367 (54.6%) cases excluded therapy completion via
the Poisson regression analysis.
Table 11
Descriptive Statistics Showing the Included and Excluded Cases of Therapy Completion
Within One Year

N

Percent

Included

305

45.4%

Excluded

367

54.6%

Total

672

100.0%

From Table 12, the Poisson regression model showed the reported tuberculosis
cases were the dependent variable of this study. Additionally, it had shown the
information on data that were overdispersed from analyzing the dependent variable of
this study. More importantly, this table had shown a mean of 108.1311, with a standard
deviation of 317.88461 of the distribution of data from the dependent variable of this
study.
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Table 12
The Descriptive Statistics of the Reported Tuberculosis Cases, The Dependent Variable
of This Study
Std.
N MinimumMaximum Mean
Dependent

Reported Tuberculosis

Variable

Cases

305

Deviation

.00 2417.00108.1377 317.88461

Of this analysis, the Omnibus test had demonstrated the likelihood ration of the
COT to improve the Poisson regression model, excluding the dependent variable. Testing
for its effect on this model, the COT was statistically significant, with p < 0.001. This
indicated an overall significant model.
In Table 13, the Poisson regression analysis showed the overall effect of COT via
the tests of model effects. From this analysis, the COT was found to be statistically
significant, with a p < 0.001 indicating that it was a predictor of the reported TB incident
cases between 1993 and 2017 in New York-Newark-Jersey City.
Table 13
The Tests of Model Effects Showing the Effect of Completion of Therapy Within One Year
on the Reported Tuberculosis Cases Via Poisson Regression Model
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Type III
Source
(Intercept)

Wald Chi-Square
303039.976

Completion of Therapy within One
Year

12297.436

Df
1

Sig.
.000

1

.000

In Table 14, the Poisson regression model displayed the exponentiated
coefficients and p-values showing a positive relationship between the COT and reported
TB incident cases in New York-Newark-Jersey City from 1993 to 2017.
Table 14
Parameter Estimates Showing the Effects of the Completion of Therapy Within One Year
Using Poisson Regression Model

Parameter
(Intercept)

95% Wald Confidence Interval for
Exp(B)
B
Sig. Exp(B)
Lower
Upper
5.199.000 181.160
179.060
183.285

No Completion of Therapy within 1.744.000
One Year
Completion of Therapy within
One Year

0a

Scale

1b

.

.175

.170

1

.

.180

A Poisson regression analysis was conducted for predicting whether the
completion of therapy within one year was a predictor of the TB incident cases from
1993 to 2017 in New York-Newark-Jersey City. In this analysis, the TB incident cases,
without therapy completion were 0.175 (95%Cl, 0.170 to 0.180, p < 0.001) times more

.
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likely to be contributed to the reoccurring TB incident cases between 1993 and 2017 from
this region of New York City. A p-value of less than 0.05, with an adjusted odds ration of
1.0 or greater indicates an increased risk of a predicting variable to influence an outcome
(Davies, Crombie, & Tavakoli, 1998). Although it was statistically significant, with a p
<0.05, the Poisson regression analysis exhibited the effect size of COT was only
estimated to 0.175 times of likelihood to influence the incident cases of TB in New YorkNewark-Jersey City during 1993-2017. With an odds ratio of 0.175, the COT variable
was less likely to influence these incident cases of TB from this area in New York City.
Since the COT variable was statistically significant, with a p < 0.001, the null
hypothesis of research question two was rejected. In contrast, the alternative hypothesis
from this question was accepted for predicting a positive relationship between the COT
and the incident cases of TB in New York-Newark-Jersey City during 1993 and 2017.
However, the likelihood of COT to influence these incident cases of TB in New YorkNewark-Jersey City was minimal.
Research Question 3 and Hypotheses
The last research question addressed the issue from testing for the isoniazid and
rifampin susceptibility (TIRS) as a predictor of the TB incident cases between 1993 and
2017 in New York-Newark-Jersey City. From this question, the independent variable,
tested for isoniazid and rifampin susceptibility was hypothesized against the dependent
variable, reported tuberculosis cases. As previously indicated, the Poisson regression
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model was used to predict the relationship between the independent and dependent
variables of this study.
As previously described, the Poisson regression model is often used for testing
the likelihood of a predicting variable in relation to a response variable. However, such a
model can exhibit several different statistical tests, with different statistical purposes in
showing such a likelihood of a predicting variable to affect an outcome of interest. As
such, in this analysis, the Poisson regression model had yielded the case processing
summary, statistics involved the categorical and continuous variables of this study,
Omnibus test, tests of a model of effects, and the parameter estimates showing the
relationship between TIRS and reported tuberculosis cases in Tables 15, 16, 17, 18, and
19.
Table 15
Descriptive Statistics Showing the Included and Excluded Cases of Isoniazid and
Rifampin Susceptibility
N

Percent

Included

308

45.8%

Excluded

364

54.2%

Total

672

100.0%

From Table 15, the Poisson regression analysis displayed the case processing
summary, which showed the numbers and percentages of included and excluded TIRS
cases of this study. Of 672 incident cases of TB, there were 308 (45.8%) cases of TIRS
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and an estimated 364 incident cases of TB were linked to the missing data of this
analysis. Notably, these 364 cases were excluded due to missing values of the TB data set
reported for New York-Newark-Jersey City from 1993 to 2017. Besides processing the
TIRS cases, the Poisson regression analysis treated it as a categorical variable.
Table 16
Descriptive Statistics Showing the Reported Cases of Isoniazid and Rifampin
Susceptibility

Factor

Tested for Isoniazid and Rifampin Yes
Susceptibility
No
Total

N

Percent

151

49.0%

157

51.0%

308

100.0%

As previously indicated, the Poisson regression model had treated the TIRS as the
categorical variable. Looking at Table 16, this analysis had revealed a total of 308 TB
incident cases of which 157 (51.0 %) of them were not associated with isoniazid and
rifampin susceptibility. Conversely, 151 (49.0%) of these cases were linked to isoniazid
and rifampin susceptibility between 1993 and 2017 in New York-Newark-Jersey City.
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In Table 17, the Poisson regression analysis showed the dependent variable,
reported tuberculosis cases of this study, was a continuous variable. This statistic test also
displayed an estimated mean of 80.8571, with a standard deviation of 217.74781
distributing the data from the response variable in Table 17.
Table 17
Descriptive Statistics of the Reported Tuberculosis Cases, the Dependent Variable of This
Study

N
Dependent
Variable

Reported
Tuberculosis Cases

308

Minimum Maximum
.00

Mean

Std.
Deviation

1576.00 80.8571 217.74781

Like in previous sections of this analysis, the Poisson regression model had
exhibited in Table 18, the Omnibus test. This statistical feature of the above statistic test
had shown the likelihood of the independent variable (TIRS) to enhance the model over
the intercept model. Specifically, when adding the TIRS variable, this model had
exhibited a significant p < 0.001 signifying a statistically significant overall model. A
resulting p < 0.001 from this statistic test indicating that the TIRS was a predictor of the
TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
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Table 18
The Tests of Model Effects Showing the Relationship Between the TIRS and Reported
Tuberculosis Cases Via the Poisson Regression Model
Type III
Source

Wald Chi-Square

df

Sig.

(Intercept)

349850.098

1

.000

Tested for Isoniazid and Rifampin

5575.982

1

.000

Susceptibility

From Table 18, the Poisson regression model had revealed the likelihood of the
TIRS to affect the incident cases of TB between 1993 and 2017 in New York-NewarkJersey City. Specifically, this statistic test had demonstrated that the TIRS was
statistically significant, with a p < 0.001 showing the overall effect of this predicting
variable on the dependent variable, reported tuberculosis cases from this area in New
York City.
Unlike the tests of model effects, the parameter estimates showed the effect sizes
and significant p-values between the predicting variable, TIRS and the TB incident cases
in New York-Newark-Jersey City during 1993-2017. From Table 19, the Poisson
regression analysis showed the incident cases of TB that tested for isoniazid and rifampin
susceptibility were 2. 94 (95%Cl, 2.853 to 3.019) times more likely to be associated with
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the TB incident cases from this area in New York City during this period. The effect size
of TIRS was supported by a statistically significant p < 0.001 indicating that this variable
was a strong predictor of the incident cases of TB in New York-Newark-Jersey City from
1993 to 2017.
Based on the resulted coefficient and p-values of this analysis, the null hypothesis
in research question three was rejected. Conversely, the alternative hypothesis was
accepted for indicating that there was a relationship between TIRS and the incident cases
of TB in New York-Newark-Jersey City from 1993 to 2017.
Table 19
The Parameter Estimates Showing the Effect of TIRS on the Reported Tuberculosis Cases
Through the Poisson Regression Model

Parameter
(Intercept)

B
3.726

Sig.
.000

Tested for
Isoniazid and
Rifampin
Susceptibility

1.077

.000

Not Tested for
Isoniazid and
Rifampin
Susceptibility

0a

Scale

1b

.

.

.

.

.

95% Wald
Confidence
Interval for
Exp(B)
Exp(B) Lower Upper
41.497 40.501 42.517

.

2.935

2.853

3.019

1

.

.
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Summary
In this quantitative analysis study, the relationship between the individuals’
race/ethnicity, age, sex(gender), and issues of completion of TB therapy within one year
and isoniazid and rifampin susceptibility, and the incident cases of TB during 1993-2017
in New York-Newark-Jersey City were investigated. As a statistical method, the Poisson
regression model was used to reveal the findings in the predictive relationship between
the independent and dependent variables of this study.
In research question number one, the hypotheses were constructed by questioning
whether the individuals’ race/ethnicity, age, and sex (gender) were related to the incident
cases of TB in New York-Newark-Jersey City. From this question, the Poisson regression
analysis showed that that race/ethnicity and covariates, age and sex were statistically
significant, with a common p < 0.001 as predictors of the incident cases of TB during
1993-2017 in New York-Newark-Jersey City. Therefore, the null hypothesis from this
question was rejected in favor of the alternative hypothesis for indicating that
race/ethnicity, age, and sex (gender) were related to these incident cases of TB from this
area in New York City.
Chapter 4 included the analysis of the COT variable against the reported
tuberculosis cases, which was the dependent variable of this study. Using the Poisson
regression test, this analysis showed that the COT was statistically significant, with a p <
0.001 indicating a positive relationship between the COT predictor and the reported TB
incident cases in New York-Newark-Jersey City during 1993-2017. Therefore, the null
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hypothesis of research question two was rejected in favor of the alternative hypothesis for
stating that there was a relationship between the COT and incident cases of TB in New
York-Newark-Jersey City from 1993 to 2017.
The last section of this analysis involved the third research question interrogating
whether the TIRS was related to the incident cases of TB in New York-Newark-Jersey
City during 1993-2017. From this question, the null hypothesis assumed that there was no
relationship between the TIRS and these incident cases of TB in New York-NewarkJersey. Conversely, the alternative hypothesis indicated that there was a relationship
between the TIRS and these incident cases of TB in New York-Newark-Jersey City
during 1993-2017.
From the Poisson regression analysis, the TIRS was found to be 2.94 (95%Cl,
2.853 to 3.019) times as likely to influence the incident cases of TB in New YorkNewark-Jersey City from 1993 to 2017. This statistic result indicated that the issue of
isoniazid and rifampin susceptibility was a strong predictor of these incident cases of TB
from this area in New York City. Thus, the null hypothesis from research question three
was rejected in favor of the alternative hypothesis for indicating that there was a
relationship between the TIRS and the incident cases of TB in New York-Newark-Jersey
City during 1993-2017. After analyzing data in chapter 4, interpretations of the data are
given in chapter 5.
Chapter 5: Discussion, Conclusions, and Recommendations
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Introduction
The purpose of this study was to investigate the relationship between the
individuals’ demographic characteristics, issues of therapy and drug susceptibility, and
the incident cases of TB in New York-Newark-Jersey City during 1993-2017. Using a
quantitative retrospective cohort design, I explored the relationship between
race/ethnicity, age, and sex (gender), issues of completion of therapy within one year,
isoniazid and rifampin susceptibility, and the TB incident cases in New York-NewarkJersey City from 1993 to 2017. The retrospective cohort design was appropriate in
conducting this study because the design is often feasible in studies involving the
investigation of several risk exposures for an outcome of interest in a large population for
a long period of time (see Setia, 2016). Likewise, this study design was the best method
for investigating the relationship between the individuals’ race/ethnicity, age, sex
(gender), issues of therapy and drug susceptibility, and TB incident cases for over 25
years in New York-Newark-Jersey City.
Using the appropriate statistical method is critical for a succinct research study. In
this quantitative analysis study, the Poisson regression model was used to analyze the
relationship between the independent and dependent variables. The UCLA, Institute for
Digital Research & Education (n.d.) noted that such a statistical method is commonly
used for predicting the relationship between various risk factors for an outcome in a given
population. The statistical model was useful for analyzing whether race/ethnicity, age,
sex (gender), and the issues of therapy completion and isoniazid and rifampin
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susceptibility were predictors of the TB incident cases from New York-Newark-Jersey
City. Using these variables, the following research questions were created by
hypothesizing whether the independent variables were related to the reported TB cases
outcome in New York-Newark-Jersey City from 1993-2017.
RQ1. Is there a relationship between race/ethnicity and covariates (age and sex),
and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey City?
H0 1. There is no relationship between race/ethnicity and covariates (age and sex),
and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
H1 1. There is a relationship between race/ethnicity and covariates (age and sex),
and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
RQ2. Is there a predictive relationship between the completion of therapy within
one year and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey
City?
H0 2. There is no predictive relationship between the completion of therapy within
one year and the TB incident cases between 1993 and 2017 in New York-Newark-Jersey
City.
H1 2. There is a predictive between completion of therapy within one year and the
TB incident cases between 1993 and 2017 in New York-Newark-Jersey City.
RQ3. Is there a predictive relationship between the cases that tested for isoniazid
and rifampin susceptibility to the TB incident cases between 1993 and 2017 in New
York-Newark-Jersey City?
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H0 3. There is no predictive relationship between the cases that tested for
isoniazid and rifampin susceptibility to the TB incident cases between 1993 and 2017 in
New York-Newark-Jersey City.
H1 3. There is a predictive relationship between the cases that tested for isoniazid
& rifampin susceptibility and the TB incident cases between 1993 and 2017 in New
York-Newark-Jersey City.
The Poisson regression is the best model for predicting several risk factors of an
issue. For this study, this statistical model was crucial in analyzing and responding to the
hypotheses. The Poisson regression model was useful in analyzing whether the predictors
of each research question were related to the response variable, reported TB cases.
Consequently, this statistical test yielded the results for the research questions and
hypotheses.
Summary of Key Findings
Research question one hypothesized whether race/ethnicity and covariates, age
and sex (gender) related to the TB incident cases between 1993 and 2017 in New YorkNewark-Jersey City. Using the Poisson regression model, the race/ethnicity variable was
used as the primary risk factor, and the age and sex (gender) demographics were
considered as the covariates in this part of the analysis. For research question one, the
Poisson regression analysis revealed that Blacks, Hispanics, and Asians were
correspondingly 2.4 (95% Cl, 2.364 to 2.512; p < 0.001), 2.1 (95% Cl, 2.031 to 2.161; p
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< 0.001), 1.8 (95% Cl, 1.782 to 1.899; p < 0.001) times as likely to be affected by TB
between 1993 and 2017 in New York-Newark-Jersey City.
Conversely, the Poisson regression model revealed that the Multi-racial and
Native Hawaiians were only 0.025 (95%Cl, 0.021 to 0.031; p < 0.001) and 0.001 (95%
Cl, 0.001 to 0.003; p < 0.001) times as likely to contribute to these incident cases of TB
between 1993 and 2017 in New York-Newark-Jersey City. Additionally, the Poisson
regression model displayed the statistics showing the relationship between the
individuals’ age, sex (gender), and incident cases of TB between 1993 and 2017 from this
area in New York City.
From this analysis, the age variable was 1.32 (95%Cl, 1.311 to 1.327, p < 0.001)
times more likely to influence their exposure to TB during this period in New YorkNewark-Jersey City. Conversely, the sex or gender variable was 1.56 (95%Cl, 1.526 to
1.584, p < 0.001) times more likely for TB to affect males than females in New YorkNewark-Jersey City. However, the coefficients and p-values were inconclusive as to
which sex (gender) or age group was more likely to influence the incident cases of TB in
New York-Newark-Jersey City from 1993 to 2017. Consequently, both age and sex
(gender) were analyzed against the incident cases of TB during this period from this area
in New York City.
Testing for sex (gender) distribution, the Poisson regression model showed a
disadvantage for males in contributing to the TB incident cases in New York-NewarkJersey City from 1993 to 2017. Specifically, this analysis revealed that males were 1.58
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(95%Cl, 1.554 to 1.613, p < 0.000) times more likely than females to have the disease
during 1993-2017 in New York-Newark-Jersey City. In addition to analyzing which sex
group was at higher risk of contributing to TB, the Poisson regression also analyzed the
individuals’ age group against the reported TB cases in New York-Newark-Jersey City.
As displayed in Table 11, the Poisson regression model revealed that the persons
whose ages were between 24-44 years, 45-64 years, 65+ years, and 15-24 years were
correspondingly 14.56 (95%Cl, 13.746 to 15. 457, p < 0.001), 9.45 (95%Cl, 8.906 to
10.035, p < 0.001), 5.96 (95%Cl, 5.605 to 6. 335, p < 0.001), 3.49 (95%Cl, 3.277 to 3.
722, p < 0.001) times more likely to influence the TB incident cases in New YorkNewark-Jersey during 1993-2017. Conversely, the likelihood of the age group 2 (i.e., 514 years) to influence the incident cases of TB was estimated to only 0.86 (95%Cl, 0.787
to 0.931, p < 0.001) times as likely to impact these phenomena of TB from 1993-2017 in
New York-Newark-Jersey City.
The coefficients were partially associated with responding to the hypotheses of
research question one. These statistical values were also statistically significant, with a
common p < 0.001, indicating a positive relationship between the individuals’
race/ethnicity, age, sex (gender), and the TB incident cases in New York-Newark-Jersey
City during 1993-2017. Consequently, the null hypothesis of research question one was
rejected. In contrast, the alternative hypothesis was accepted because there was a
relationship between the race/ethnicity, age, and sex (gender) demographics and the TB
incident cases between 1993 and 2017 in New York-Newark-Jersey City.
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In the second research question, the COT was hypothesized as the predictor of the
TB incident cases between 1993 and 2017 in New York-Newark-Jersey City. Using the
Poisson regression model, the COT was treated as the risk factor to be analyzed against
the response variable, reported TB cases of this study. From this analysis, the Poisson
regression showed that the cases without COT were only 0.175 (95%Cl, 0.170 to 0.180, p
< 0.001) times as likely to influence the incident cases of TB during 1993-2017 in New
York-Newark-Jersey City. As previously indicated, such a coefficient value was small
and suggested that the COT was less likely to influence these incident cases of TB during
this period in New York-Newark-Jersey City.
Despite being small, the coefficient value of the COT variable was statistically
significant, with a p < 0.001. Therefore, the null hypothesis in research question two was
rejected. Conversely, the alternative hypothesis of this question was accepted for
indicating that there was a relationship between the COT and TB incident cases between
1993 and 2017 in New York-Newark-Jersey City.
The last research question of this study was based on the hypothesis of whether
testing for isoniazid and rifampin susceptibility (TIRS) was related to the incident cases
of TB in New York-Newark-Jersey City from 1993 to 2017. Consequently, the Poisson
regression model was used to analyze the TIRS variable against the reported TB cases,
which was the dependent variable of this research. From this analysis, the TIRS variable
was found to be 2.935 (95%Cl, 2.853 to 3.019; p < 0.001) times as likely to influence the
phenomena of TB incidence in New York-Newark-Jersey City during 1993-2017. Thus,
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it was likely to say that the TIRS was a strong predictor of the incident cases of TB from
this area in New York City. Often, the findings of a research study are crucial in
conforming or disconfirming previous outcomes and theory related to such a study.
Interpretation of the Findings
As a reminder, this study was guided by the epidemiological triad theory. Such a
philosophical perspective assumes that the age, sex (gender), and environmental risk
factors (e.g., geology, climate, biological, and socioeconomic status) can influence the
occurring incidence of an infectious disease a given population (CDC, 2012). The
socioeconomic status may be defined as the issues in crowding, sanitation, and
availability of health services in such a population (CDC, 2012). Speaking of theory,
Trafimow (2013) indicated that the assumptions of a theory often allow researchers to
predict the cause and effect of an outcome in an environment. Similarly, the assumptions
of the epidemiological triad theory were adopted in investigating the relationship between
the individuals’ race/ethnicity, age, sex(gender), COT, TIRS, and the reported TB
incident cases in New York-Newark-Jersey City.
The epidemiological triad theory assumes the individuals’ age and sex are
intrinsic risk factors for exposing them to an infectious disease. Likewise, in this study,
the race/ethnicity, age, and sex (gender) demographics were found to be strong predictors
of the TB incident cases in New York-Newark-Jersey City from 1993 to 2017.
The assumptions of a theory must be interrelated with the findings of a research
study. Trafimow (2013) indicated that the findings of a research study can be used to
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confirm or disconfirm both the theoretical perspectives and previous findings related to
the subject under the investigation. As such, the data analysis of this study revealed that
the individuals’ age and sex were statistically significant, with a p-value p < 0.001
indicating that the above variables were strong predictors of the TB incident cases in New
York-Newark-Jersey City during this period above.
The above statistical results were useful in confirming that both age and sex
demographics were related to the incident cases of TB between 1993 and 2017 from New
York-Newark-Jersey City. Most often, researchers investigated other risk factors that
were not suggested by the theories of their studies (Trafimow, 2013). Likewise, this study
investigated other risk factors, such as race/ethnicity and issues of therapy completion
and isoniazid and rifampin susceptibility.
The race/ethnicity demographic is currently an influential risk factor for TB,
globally. Noppert et al. (2017) and Wilson et al. (2016) indicated that the race/ethnicity
risk factor is commonly associated with the incidence of TB in the United States.
Likewise, the findings of this study showed that race/ethnicity was statistically
significant, with a p < 0.001 indicating that race/ethnicity was a predictor of the TB
incident cases for the past 25 years in New York-Newark-Jersey City. Therefore, the
inclusion of race/ethnicity as a risk factor for an infectious disease is strongly suggested
for improving the epidemiological triad theory. Also, the issues of therapy and drug
susceptibility impacted the incidence of TB worldwide.
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As such, the COT and TIRS were directly related to the incident cases of TB in
New York-Newark-Jersey City during 1993-2017. Bhavnani et al. (2015) argued about
this issue by indicating that the lack of therapy completion has an influence on the
incident cases of TB in New York City. Likewise, the WHO (2018) reported that both
therapy and drug susceptibility issues have recently prevented the efforts of health care
providers and public health professionals from eradicating TB in the world.
Consequently, in this study, I investigated the relationship between COT, TIRS, and
incident cases of TB from 1993 to 2017 in New York-Newark-Jersey City.
Both the COT and TIRS were found to be statistically significant, with a p <
0.001 as one of the predictors of the incident cases of TB between 1993 and 2017 in New
York-Newark-Jersey City. However, there was a major gap in the literature of TB,
whereby previous studies had not thoroughly investigated the relationship between the
COT, TIRS, and these incident cases of TB in New York-Newark-Jersey City and the
United States. Therefore, the findings of this research were of great public health
significance by filling this gap in the literature of TB research in New York-NewarkJersey City and the United States. Additionally, the findings of this study were critically
important for advancing knowledge in the TB research discipline
Limitations of the Study
Using the 1993-2017 TB data set of the CDC wonder’s website was a limitation
to this study. The CDC agency organized this data set into the group level, which made
the findings of this study susceptible to ecologic bias. Such a type of bias has often arisen
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from the loss of data or information of a grouped data set (Greenland, 2001; Wakefield,
2008, Webster, 2002). Using an aggregate or grouped data set often prevented
researchers from interpreting the findings of their studies at individual levels (Greenland,
2001; Wakefield, 2008, Webster, 2002). Likewise, the 1993-2017 TB data set contained
some missing data and cases, with zero values for a unique ethnic group (CDC, 2018).
This partially represented an ecologic bias of this study.
Ecologic bias can be observed in individual-based research. Webster (2002)
indicated that it is possible to have a partial ecologic bias in the findings of the
individual-based public health research studies. Often, such an issue was based on the
measurement errors of the risk exposures from an aggerate data set (Webster, 2002). To
avoid the ecologic bias in interpreting the findings of an individual-based research study,
researchers must interpret these findings by group level (Krause, 2017). Such a
suggestion was used to interpret the issue of missing data cases, with zero values of an
ethnic group of TB patients in New York-Newark-Jersey City during 1993-2017.
As previously indicated, this study was conducted using the 1993-2017 TB data
set from the CDC’s website. This data set included cases, with zero values from a certain
ethnic group of TB patients in New York-Newark-Jersey City (CDC, 2018). However,
the incident cases, with zero values were not indicative of whether this ethnic group was
not affected by the TB incident cases from this area in New York City during 1993-2017
(CDC, 2018). In research, such an issue is problematic and often called zero-inflated or
excess of zero counts of a data set (UCLA, Institute for Digital Research & Education,
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n.d.). Not all statistical models can be used for analyzing counted data, with excess zero
values.
Often, the zero-inflated issue has limited certain studies to using fewer statistical
methods. Likewise, the excess zero values limited the data analysis of this study to either
use the Poisson regression or negative binomial models. As previously indicated in the
methodology section, the Poisson regression model was appropriate for analyzing the
data of this study. Because of the excess zero values, the Poisson regression model failed
to exhibit a mean value that was equal to the variance in the descriptive statistics
displayed in Table 1. So, the reported tuberculosis cases (e.g., dependent variable)
violated the assumption of probability distribution because of the overdispersed data from
the 1993-2017 TB data set.
The overdispersed data issue was previously seen in studies of counted data using
the Poisson regression test. Therefore, such an issue could not prevent the analysis of data
from this study using the Poisson regression model. Instead, the Omnibus test was
statistically significant, with a p < 0.001 indicating the likelihood of all predicting
variables of this study to improve the Poisson regression model. Therefore, the
interpretation of results from this analysis proceeded.
The uncertainty about the attribution of one ethnic group could not affect the
generalizability of the findings of this study in New York-Newark-Jersey City.
Contrarily, this study involved the investigation of 672 incident cases of TB from six
major ethnic groups from this area in New York City. This research also included the TB
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patients of both gender groups (e.g., males & females) from all age groups (e.g., 0-65 and
older) in New York-Newark-Jersey City. Therefore, the limitation of this study was
minimal and couldn’t affect the generalizability of its findings to represent the population
of the TB disease from this region in New York. After evaluating the limitation of this
research, the following recommendations were provided for future TB researches in New
York-Newark-Jersey City.
Recommendations for Future Studies
The New York-Newark-Jersey City is among the most vulnerable regions for the
reoccurrence of TB incidence in the United States. In 2018, the incidence rate of TB has
been slowly declined from 7.5 in 2017 to 6.8 in New York City (New York City
Bureau of the Tuberculosis Control, 2018). Despite declining, this infectious disease has
remained to be dangerous among the inhabitants in New York-Newark-Jersey City. As
previously indicated, the data of TB patients among some ethnic groups were unavailable
in the 1993-2017 TB data set. Therefore, the unavailability of data from these patients
represented a limitation to this study. However, such a limitation was minimal and
couldn’t prevent the generalizability of the findings of this TB research in New YorkNewark-Jersey City.
It is doubtful in accepting that the TB incidence rate is currently declining in New
York-Newark-Jersey City. Recently, the New York City Department of Health has
reported that the TB incidence rate of TB is estimated at 6.8 per 100,000 persons.
However, there is still uncertainty as to whether this report is accurate. Such a statement

110
is relevant because of the missing data and cases, with the excess zero values that were
reported for some TB patients in the OTIS database. Based on this issue, it is strongly
recommended that further TB researches be conducted on the reasons why the attribution
of a certain ethnic group of TB patients was not reported in the OTIS database between
1993 and 2017 in New York-Newark-Jersey City.
The strength of this research was greater than its limitation. As a reminder, this
study suggested the justification in the issues of TB therapy completion and drug
susceptibility as predictors of the TB incidence in New York-Newark-Jersey City. Such a
suggestion has been confirmed by the statistically significant, with a p < 0.001 indicating
a positive relationship between the COT, TIRS, and the TB incident cases in New YorkNewark-Jersey City. Currently, little research is done on the above issues in relation to
the incident cases of TB in New York-Newark-Jersey City. Consequently, based on the
findings of this research, it is strongly recommended that future studies be conducted on
the issues connected to therapy completion and isoniazid and rifampin susceptibility as
the preventable risk factors for TB in New York-Newark-Jersey City.
Implications of Social Change
The findings of this study might impact a positive social change among ethnic
minorities New York-Newark-Jersey City. Maton (2008) indicated that a positive social
change may be done by empowering the burdened groups of persons in a given
community or society. In New York-Newark-Jersey City, the Asian, Black, and Hispanic
ethnic minorities have represented the burdened ethnic groups of persons, with the
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highest tuberculosis incident cases for the past two decades. For many years, researchers
have repeatedly revealed the vulnerability of these ethnic groups in acquiring TB from
this area in New York City.
Likewise, in this study, the findings showed that the Asians, Blacks, and
Hispanics have been disproportionately affected by the incident cases of TB in New
York-Newark-Jersey City from 1993 to 2017. Consequently, the results of this research
might create a positive social change by influencing public health professionals in
designing an effective TB intervention addressing the individuals’ race/ethnicity as a risk
factor to reduce the burden of TB from this region in New York City. However, other
ethnic groups will be benefited from this initiative in New York- Newark-Jersey City.
It will be important for such TB intervention to be designed in order to prevent
TB among persons of other ethnicities in New York-Newark-Jersey City. Maton (2008)
also indicated that bringing a positive social change into a community must not exclude
certain ethnic groups of this environment. From this study, the Multi-racial and Native
Hawaiians have been correspondingly categorized as fourth and fifth ethnic groups that
were affected by the incident cases of TB between 1993 and 2017 from the above area in
New York City. Therefore, the findings of this study also suggested the design of such a
TB intervention about reducing TB among these ethnic groups above in New YorkNewark-Jersey City.
An effective TB intervention must be initiated for empowering both the ethnic
minorities and persons of other ethnicities in New York-Newark-Jersey City. However,
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fulfilling such a task may require public health professionals to be aware of the
circumstances or conditions that might expose the residents of a community to an
infectious disease (CDC, 2012). Thus, it is strongly suggested that these public health
servants investigate the environmental risk factors that might influence the exposure of
the inhabitants of New York-Newark-Jersey City to TB.
Environmental risk factors may have different definitions. According to the CDC
(2012), they are the individuals’ socio-economic status, lack of health care, social
conditions, and behavioral issues that have often evoked the incidence of an infectious
disease in a given population. As such, the behavioral issues, such as misconception
about TB prevention and care, substance, and alcohol use, and refusal of HIV testing had
impacted the TB incident cases in New York-Newark-Jersey City (Dawson et al., 2016;
Howley et al., 2015; Katyal et al., 2018; Knorr et al., 2013; Marks et al., 2016; Stennis et
al., 2017; Zelnick et al., 2016). Other issues were found to be associated with the above
incident cases of TB from this area in New York City.
Both therapy and lack of access to TB care impacted these incident cases of TB in
New York-Newark-Jersey City. For instance, the issues of therapy incompletion and lack
of health insurance have been associated risk factors for TB among patients of diverse
ethnic groups in New York-Newark-Jersey City (Bhavnani et al., 2015; Marks et al.,
2016; Knorr et al., 2013; Kyanko et al., 2016; Stennis et al., 2017; Zelnick et al., 2016).
Likewise, the findings of this study showed that the issues of therapy incompletion and
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isoniazid and rifampin susceptibility were associated with the incident cases of TB
between 1993 and 2017 in New York-Newark-Jersey City.
Using the above statistical findings from this research, public health professionals
will be better equipped for designing an effective TB intervention for New York-NewarkJersey City. With the help of this study, such inspiring TB intervention will be brought a
positive social change by empowering the residents, regardless of their race/ethnicity,
age, or sex orientations to change their behaviors towards TB prevention and care from
this region in New York City.
The findings of this study will provoke the public health servants to investigate
how patients of certain ethnic groups have been disproportionately affected by the
escalation of TB in New York-Newark-Jersey City. Therefore, knowing about the
reasons for such a high burden of TB incidence among the Asian, Black, and Hispanic is
imperative for designing a new TB intervention from the above area in New York City.
This research will be informative to both public health professionals and health
care providers in New York-Newark-Jersey City. As such, its findings will help in
improving their knowledge in tuberculosis practice by providing the quality of care they
have desired to deliver to their TB patients in New York-Newark-Jersey City.
The positive social change of a situation often accompanies a change of policy
concerning that issue in an environment. Likewise, the findings of this research are
subjected to influence the public health professionals to oversee the policy regarding
healthcare for TB patients, regardless of their immigration status in New York-Newark-
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Jersey City. In cases of a change or modification of the law that governs the health care
for TB patients, it will be likely that the lack of access to TB care issues will be
eliminated by allowing access for TB care among all TB patients across this region in
New York City. Based on these preventive measures, the incidence of TB will be
prevented or reduced in New York-Newark-Jersey City.
Conclusion
The findings of this research were of great public health significance by showing
the individuals’ race/ethnicity was the primary predictor of the TB incident cases between
1993 and 2017 in New York-Newark-Jersey City. As such, the results of this research
demonstrated that the age and sex (gender) covariates have been influential risk factors in
these incident cases of TB from this area in New York City. More importantly, the
findings of this research had justified that both inadequate therapy completion and
isoniazid and rifampin susceptibility were associated with these incident cases of TB
between during the period in New York-Newark-Jersey City. As previously indicated,
both COT and TIRS were statistically significant, with a p < 0.001 indicating that they
were two of the predictors of the TB incident cases between 1993 and 2017 in New YorkNewark-Jersey City.
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